EOS Med Chem Impurity Stock 20201029-14

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

16,16-Dimethyl Prostaglandin A1, CAS: 41692-24-4, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₄.

16,16-Dimethyl Prostaglandin A2, CAS: 41691-92-3, stock: 6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄O₄.

16,16-Dimethyl Prostaglandin E2, CAS: 39746-25-3, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₅.

17- Phenyl Trinor Prostaglandin F2α Methyl Amide, CAS: 155206-01-2, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅NO₄.

17- Phenyl Trinor Prostaglandin F2α Methyl Amide (10mg/mL in Ethanol), CAS: 155206-01-2, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅NO₄.

17-Phenyl-18,19,20-trinor-PGF2α 1,15-Lactone, CAS: /, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₄.

17-Phenyl-trinor-prostaglandin E2, CAS: 38315-43-4, stock: 9.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₅.

19(R)-Hydroxy-prostaglandin E2, CAS: 64625-54-3, stock: 1.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₆.

2,3,4,5-Tetranor-misoprostol Acid, CAS: /, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈O₅.

2,3-Dinor iPF2α-III, CAS: 221664-05-7, stock: 8.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀O₅.

2,3-Dinor iPF2α-III-d9, CAS: /, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁D₉O₅.

2-Amino-4-(1-naphthyl)thiazole, CAS: 56503-96-9, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂S.

2-Iodopyridine, CAS: 5029-67-4, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄IN.

3-Methoxy-2-pentenoic Acid Methyl Ester, CAS: 104065-67-0, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₃.

3β-Benzoyloxy-2β-carboxaldehyde-5α-hydroxy-1α-cyclopentaneacetic Acid γ-Lactone, CAS: 39746-01-5, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₅.

4,4’-Diisothiocyanatostilbene-2,2’-disulfonic Acid Disodium Salt, CAS: /, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈N₂Na₂O₆S₄.

4,5-Dihydro-5-methyl-d3-3,4-diphenyl-5-isoxazolol, CAS: /, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂D₃NO₂.

4-Methyl-1-octen-4-ol, CAS: 62108-06-9, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O.

4-Pentyne-1-thiol (>90%), CAS: 77213-88-8, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈S.

4-trans-Prostaglandin E2, CAS: /, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₅.

5,6-trans Travoprost, CAS: 1563176-59-9, stock: 3.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅F₃O₆.

5-(Diphenylphosphoryl)-N-ethylpentanamide, CAS: /, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄NO₂P.

5-trans-Prostaglandin E2, CAS: 36150-00-2, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₅.

5-[[3-Bromo-4-(2-cyclohexylethoxy)phenyl]methylene]-2,4-thiazolidinedione, CAS: 1239610-74-2, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀BrNO₃S.

5-[[3-Bromo-4-(2-cyclohexylethoxy)phenyl]methylene]-2,4-thiazolidinedione-d4, CAS: 1795135-31-7, stock: 9.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₄BrNO₃S.

5-[[3-Chloro-4-(2-cyclohexylethoxy)phenyl]methylene]-2,4-thiazolidinedione, CAS: 1239610-72-0, stock: 1.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀ClNO₃S.

5-[[3-Chloro-4-(2-cyclohexylethoxy)phenyl]methylene]-2,4-thiazolidinedione-d4, CAS: 1795137-28-8, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₄ClNO₃S.

5-[[4-(2-Cyclohexylethoxy)-3-methoxyphenyl]methylene]-2,4-thiazolidinedione, CAS: 1239610-60-6, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₄S.

5-[[4-(2-Cyclohexylethoxy)-3-methoxyphenyl]methylene]-2,4-thiazolidinedione-d4, CAS: 1795143-97-3, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉D₄NO₄S.

6,15-Diketo-13,14-dihydro-PGF1α, CAS: 63983-53-9, stock: 8.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₆.

6-Ketoprostaglandin F1α, CAS: 58962-34-8, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₆.

6-Ketoprostaglandin F1α-d9, CAS: /, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₉O₆.

6-trans-Prostaglandin E2, CAS: /, stock: 8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₅.

8-des(6-Carbomethoxy-hexyl) 8-(Carboxypropyl-d4) Misoprostol, CAS: /, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄D₄O₅.

8-epi-Prostaglandin F2α, CAS: 27415-26-5, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₅.

8-epi-Prostaglandin F2α 8-Glucuronide, CAS: /, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂O₁₁.

8-epi-Prostaglandin F2α-d9, CAS: /, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₉O₅.

8-iso Misoprostol, CAS: /, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₈O₅.

8-Isoprostaglandin F1α-d9, CAS: /, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇D₉O₅.

9alpha,11beta-PGF2 (9alpha,11beta-Prostaglandin F2), CAS: 38432-87-0, stock: 1.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₅.

9beta,11alpha-Prostaglandin F2, CAS: 4510-16-1, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₅.

AH 13205, CAS: 148436-63-9, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆O₄.

AH-6809, CAS: 33458-93-4, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O₅.

Angoroside C, CAS: 115909-22-3, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₈O₁₉.

AT-56, CAS: 162640-98-4, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇N₅.

Bimatoprost, CAS: 155206-00-1, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇NO₄.

Bimatoprost 13,14-Epoxide, CAS: /, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇NO₅.

Bimatoprost Acid, CAS: 38344-08-0, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂O₅.

Bimatoprost Acid Methyl Ester, CAS: 38315-47-8, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₅.

Bimatoprost-d5, CAS: /, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂D₅NO₄.

Bovine HPGD (15-hydroxyprostaglandin dehydrogenase [NAD(+)]) ELISA Kit (96T), CAS: /, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine PGF2α Synthase(Prostaglandin F2 alpha synthase) ELISA Kit (96T), CAS: /, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine PGF2α(Prostaglandin F2α) ELISA Kit (96T), CAS: /, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine PTGDR (Prostaglandin D2 receptor) ELISA Kit (96T), CAS: /, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine PTGES (Prostaglandin E synthase) ELISA Kit (96T), CAS: /, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine PTGES(Prostaglandin E synthase) ELISA Kit (96T), CAS: /, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine PTGES2 (Prostaglandin E synthase 2) ELISA Kit (96T), CAS: /, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine PTGES3 (Prostaglandin E synthase 3) ELISA Kit (96T), CAS: /, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Canine Prostaglandin F Metabolite ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Carboprost, CAS: 35700-23-3, stock: 5.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆O₅.

Chicken HPGDS (Hematopoietic prostaglandin D synthase) ELISA Kit (96T), CAS: /, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chicken PTGES3 (Prostaglandin E synthase 3) ELISA Kit (96T), CAS: /, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Cloprostenol, CAS: 40665-92-7, stock: 6.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉ClO₆.

d-Cloprostenol Sodium Salt, CAS: 62561-03-9, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈ClNaO₆.

delta12-PGJ2 (delta12-Prostaglandin J2), CAS: 87893-54-7, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₄.

Deprostil, CAS: 33813-84-2, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₈O₄.

Des-N-Ethylhex-5-enamide 6-Hydroxybimatoprost, CAS: /, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆O₄.

Enisoprost, CAS: 81026-63-3, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₅.

ent-Lubiprostone, CAS: /, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂F₂O₅.

ER 819762, CAS: 1155773-15-1, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₉N₃O₃.

Ethyl Caproate, CAS: 123-66-0, stock: 4.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₂.

Ethyl Caproate-d11, CAS: 2159-19-5, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₁₁O₂.

Ethyl-d5 Caproate, CAS: 1082581-90-5, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁D₅O₂.

FCE 20700, CAS: 89648-76-0, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄O₄.

Fenprostalene, CAS: 69381-94-8, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₆.

Fevipiprant-13CD3, CAS: /, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³CH₁₄D₃F₃N₂O₄S.

Fluprostenol, CAS: 40666-16-8, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉F₃O₆.

Gemeprost, CAS: 64318-79-2, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₈O₅.

Human EP2(Prostaglandin E Receptor 2 ) ELISA Kit (96T), CAS: /, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PGD2S(Prostaglandin D2 Synthase, Brain) ELISA Kit (96T), CAS: /, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PGE2(Prostaglandin E2) ELISA Kit (96T), CAS: /, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PGF2α(Prostaglandin F2α) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PTGDR (Prostaglandin D2 receptor) ELISA Kit (96T), CAS: /, stock: 8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PTGDR(Prostaglandin D2 receptor) ELISA Kit (96T), CAS: /, stock: 3.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PTGES (Prostaglandin E synthase) ELISA Kit (96T), CAS: /, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PTGES(Prostaglandin E synthase) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PTGES3 (Prostaglandin E synthase 3) ELISA Kit (96T), CAS: /, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PTGES3(Prostaglandin E synthase 3) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PTGIS(Prostaglandin I Synthase) ELISA Kit (96T), CAS: /, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PTGS1(Prostaglandin G/H synthase 1) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Isopropyl Cloprostenate, CAS: 157283-66-4, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅ClO₆.

L-670,596, CAS: 121083-05-4, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁F₂NO₄S.

Mead Acid (20:3, n-9), CAS: 20590-32-3, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₂.

Meteneprost, CAS: 61263-35-2, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₈O₄.

Meteneprost-d9, CAS: /, stock: 1.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉D₉O₄.

MF 63, CAS: 892549-43-8, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₁ClN₄.

Misoprostol, CAS: 59122-46-2, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₈O₅.

Misoprostol, 1% in cellulose, CAS: 59122-46-2, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₈O₅.

ML148, CAS: 451496-96-1, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁N₃O.

Monomethyl Suberate, CAS: 3946-32-5, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₄.

Mouse Hpgd (15-hydroxyprostaglandin dehydrogenase [NAD(+)]) ELISA Kit (96T), CAS: /, stock: 8.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Hpgds (Hematopoietic prostaglandin D synthase) ELISA Kit (96T), CAS: /, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse PGD2S(Prostaglandin D2 Synthase) ELISA Kit (96T), CAS: /, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse PGE2(Prostaglandin E2) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse PGF2α(Prostaglandin F2 Alpha) ELISA Kit (96T), CAS: /, stock: 1.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Ptgdr (Prostaglandin D2 receptor) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Ptges (Prostaglandin E synthase) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse PTGES(Prostaglandin E Synthase, Microsomal) ELISA Kit (96T), CAS: /, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Ptges2 (Prostaglandin E synthase 2) ELISA Kit (96T), CAS: /, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Ptges3 (Prostaglandin E synthase 3) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse PTGS1(Prostaglandin Endoperoxide Synthase 1) ELISA Kit (96T), CAS: /, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse PTGS2/COX-2(Prostaglandin Endoperoxide Synthase 2) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

N-Cyclopropyl Bimatoprost, CAS: 1138395-12-6, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇NO₄.

N-Cyclopropyl Methyl Bimatoprost, CAS: 1138395-10-4, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉NO₄.

N-Ethyl Fluprostenol Carboxamide, CAS: 1005193-64-5, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄F₃NO₅.

N-Ethylaniline, CAS: 103-69-5, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N.

N-Ethylaniline-d5, CAS: 844665-21-0, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₅N.

N-Norbimatoprost, CAS: 155205-89-3, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃NO₄.

Nocloprost, CAS: 79360-43-3, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₇ClO₄.

Octyl Maleimide, CAS: 4080-76-6, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₂.

PGB2 (Prostaglandin B2), CAS: 13367-85-6, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₄.

PGE-M, CAS: 24769-56-0, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄O₇.

PGF1alpha (Prostaglandin F1alpha), CAS: 745-62-0, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₆O₅.

PGF2α(Prostaglandin F2 Alpha) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

PGH2 (Prostaglandin H2), CAS: 42935-17-1, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₅.

PGJ2 (Prostaglandin J2), CAS: 60203-57-8, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₄.

Porcine PGE2(Prostaglandin E2) ELISA Kit (96T), CAS: /, stock: 1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Porcine PGF2α(Prostaglandin F2α) ELISA Kit (96T), CAS: /, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Prostaglandin A1, CAS: 14152-28-4, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₄.

Prostaglandin A1 ethyl ester, CAS: 93464-24-5, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₄.

Prostaglandin A2, CAS: 13345-50-1, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₄.

Prostaglandin D1, CAS: 17968-82-0, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₅.

Prostaglandin D2 Dopamine, CAS: /, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁NO₆.

Prostaglandin D2 Ethanolamide-d4, CAS: /, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃D₄NO₅.

Prostaglandin E0, CAS: 19313-28-1, stock: 2.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₆O₅.

Prostaglandin E0-d4, CAS: /, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂D₄O₅.

Prostaglandin E1, CAS: 745-65-3, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₅.

Prostaglandin E1-d4, CAS: 211105-33-8, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀D₄O₅.

Prostaglandin E2, CAS: 363-24-6, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₅.

Prostaglandin E2 Ethanolamide-d4, CAS: 194935-38-1, stock: 4.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃D₄NO₅.

Prostaglandin E2-d4, CAS: 34210-10-1, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈D₄O₅.

Prostaglandin F2α-d4, CAS: 34210-11-2, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀D₄O₅.

Prostaglandin F2α-d9, CAS: /, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₉O₅.

Rabbit PTGS1(Prostaglandin Endoperoxide Synthase 1) ELISA Kit (96T), CAS: /, stock: 4.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

rac-Enprostil, CAS: 73121-56-9, stock: 4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₆.

Rat EP2(Prostaglandin E Receptor 2) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Hpgd (15-hydroxyprostaglandin dehydrogenase [NAD(+)]) ELISA Kit (96T), CAS: /, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Hpgds (Hematopoietic prostaglandin D synthase) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat PGE2(Prostaglandin E2) ELISA Kit (96T), CAS: /, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat PGF2α(Prostaglandin F2 Alpha) ELISA Kit (96T), CAS: /, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Ptgdr (Prostaglandin D2 receptor) ELISA Kit (96T), CAS: /, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Ptgds(Prostaglandin-H2 D-isomerase) ELISA Kit (96T), CAS: /, stock: 7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat PTGES(Prostaglandin E Synthase, Microsomal) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Ptges3 (Prostaglandin E synthase 3) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat PTGIS (Prostaglandin I Synthase) ELISA Kit (96T), CAS: /, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat PTGS1(Prostaglandin G/H synthase 1) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat PTGS2/COX-2(Prostaglandin G/H synthase 2) ELISA Kit (96T), CAS: /, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Resatorvid, CAS: 243984-11-4, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇ClFNO₄S.

Roburic Acid, CAS: 6812-81-3, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₈O₂.

S 5751, CAS: 209268-36-0, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁NO₄S.

SAR191801, CAS: 1234708-04-3, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀N₆O₃.

SC-51089, CAS: 146033-02-5, stock: 3.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀Cl₂N₄O₃.

Sheep PGE2(Prostaglandin E2) ELISA Kit (96T), CAS: /, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Suprofen, CAS: 40828-46-4, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₃S.

Suprofen-d3, CAS: 126320-79-4, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉D₃O₃S.

SW033291, CAS: 459147-39-8, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀N₂OS₃.

tert-Butyldimethyl((4-methyloct-1-en-4-yl)oxy)silane, CAS: /, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₂OSi.

Tiaprost, CAS: 71116-82-0, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₆S.

Timegadine, CAS: 71079-19-1, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃N₅S.

trans-1-Methyl-2-(4-methylpentyl)cyclopentane, CAS: 66553-50-2, stock: 4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄.

trans-Carboprost, CAS: 76498-29-8, stock: 2.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆O₅.

Travoprost, CAS: 157283-68-6, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅F₃O₆.

Travoprost 13,14-Epoxide (Mixture of Diastereomers), CAS: /, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅F₃O₇.

Travoprost Acid, CAS: 54276-17-4, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉F₃O₆.

Travoprost-d4, CAS: /, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁D₄F₃O₆.

Travoprost-d4 Acid, CAS: 282550-19-0, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅D₄F₃O₆.

U-44069, CAS: 56985-32-1, stock: 8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄O₄.

Universal 6-keto-PGF1a(6-keto-prostaglandin F1a) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Universal 8-epi-PGF2α(8-Epi-Prostaglandin F2 Alpha) ELISA Kit (96T), CAS: /, stock: 5.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Universal PGE2(Prostaglandin E2) ELISA Kit (96T), CAS: /, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Valdecoxib, CAS: 181695-72-7, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂O₃S.

Valdecoxib-13C2,15N, CAS: 1189428-23-6, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³CH₁₄N¹⁵NO₃S.

Valdecoxib-d3, CAS: 1219794-90-7, stock: 2.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₃N₂O₃S.

Viprostol, CAS: 73647-73-1, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₆O₅.

[3aR,4R(1E,3S),5R,6aS]-5-Benzoyloxy-4-(3-hydroxy-4-phenoxy-1-buten-1-yl)-hexahydro-2H-cyclopenta[b]furan-2-one, CAS: 208111-89-1, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃ClO₆.

Ethyl Butyrylacetate-d5, CAS: /, stock: 9.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₅O₃.

Propylthiouracil, CAS: 51-52-5, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂OS.

Propylthiouracil 2,3,4-Tri-O-acetyl-N-β-D-glucuronide Methyl Ester, CAS: /, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O₁₀S.

Propylthiouracil N-β-D-Glucuronide Methyl Ester, CAS: /, stock: 8.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₇S.

Propylthiouracil N-β-D-Glucuronide Sodium Salt, CAS: /, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₂NaO₇S.

Propylthiouracil-d5, CAS: 1189423-94-6, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₅N₂OS.

Propylthiouracil-d5 2,3,4-Tri-O-acetyl-N-β-D-glucuronide Methyl Ester, CAS: /, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₅N₂O₁₀S.

Propylthiouracil-d5 N-β-D-Glucuronide Sodium Salt, CAS: /, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₅N₂NaO₇S.

Pyrazinamide, CAS: 98-96-4, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₃O.

Pyrazinamide-15N,d3, CAS: 1246817-81-1, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂D₃N₂¹⁵NO.

Pyrazinamide-d3, CAS: 1432059-16-9, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂D₃N₃O.

2,3,4-Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester Propan-2-ol-D6, CAS: /, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₆O₁₁.

Dipropylene Glycol Diacrylate, CAS: 57472-68-1, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₅.

Ethyl Vanillin Propylene Glycol Acetal, CAS: 68527-76-4, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₄.

Polyoxyethylene (25) Propylene Glycol Stearate, CAS: 37231-60-0, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆O₂ •  (C₃H₆O•C₂H₄O)ₓ.

Propylene Glycol 1-Glucuronide Sodium Salt (Mixture of Diastereomers), CAS: /, stock: 7.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NaO₈.

Propylene Glycol 2-Glucopyranosiduronic Acid Methyl Ester 2,3,4-Triacetate, CAS: /, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄O₁₁.

Propylene Glycol 2-Glucuronide Sodium Salt (Mixture of Diastereomers) (>85%), CAS: /, stock: 10g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NaO₈.

Propylene Glycol 2-α-Glucopyranosiduronic Acid Benzyl Ester 2,3,4-Triacetate, CAS: /, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₁₁.

Propylene Glycol 2-β-Glucopyranosiduronic Acid Benzyl Ester 2,3,4-Triacetate, CAS: /, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₁₁.

Propylene Glycol 2-β-Glucopyranosiduronic Acid Benzyl Ester 2,3,4-Triacetate Ammonium Salt, CAS: /, stock: 10g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁NO₁₁.

Propylene Glycol 2-β-Glucopyranosiduronic Acid Benzyl Ester-d6, CAS: /, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₆O₈.

Propylene Glycol β-D-Glucopyranosiduronic Acid Benzyl Ester 2,3,4-Triacetate-d6, CAS: /, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄D₆O₁₁.

Propylene Glycol β-D-Glucopyranosiduronic Acid Methyl Ester 2,3,4-Triacetate, CAS: /, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄O₁₁.

Propylene Glycol-d6 1-Glucuronide (Mixture of Diastereomers) Sodium Salt, CAS: /, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉D₆NaO₈.

Propylene Glycol-d6 2-Glucuronide Sodium Salt (Mixture of Diastereomers), CAS: /, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉D₆NaO₈.

Tripropylene Glycol Diacrylate, Mixture of Isomers, CAS: 42978-66-5, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₆.

Vitamin D2, CAS: 50-14-6, stock: 6.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O.

Vitamin D2-d3, CAS: /, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁D₃O.

Vitamin D2-d6, CAS: 1311259-89-8, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈D₆O.

(R)-4-Hydroxy Propranolol Hydrobromide, CAS: /, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂BrNO₃.

(R)-Propranolol β-D-Glucuronide Sodium Salt, CAS: 87102-70-3, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈NNaO₈.

(R)-Propranolol-d7 β-D-Glucuronide Sodium Salt, CAS: /, stock: 7.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₇NNaO₈.

(S)-4-Hydroxy Propranolol Hydrobromide, CAS: 135201-50-2, stock: 6.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂BrNO₃.

(S)-Propranolol β-D-Glucuronide Sodium Salt, CAS: 87144-73-8, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈NNaO₈.

(S)-Propranolol-d7 β-D-Glucuronide Sodium Salt, CAS: /, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₇NNaO₈.

1-(Azidomethyl)-2-(1-naphthalenyloxy)ethyl β-D-Glucopyranosiduronic Acid Methyl Ester 2’,3’,4’-Triacetate, CAS: /, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉N₃O₁₁.

1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione, CAS: 345931-85-3, stock: 1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₄.

1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione-d7, CAS: 1794942-05-4, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₇NO₄.

2-Hydroxypropranolol, CAS: 76275-54-2, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃.

2-Hydroxypropranolol-d5, CAS: /, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₅NO₃.

4-Hydroxy Propranolol β-D-Glucuronide (Mixture of Diastereomers), CAS: 94731-13-2, stock: 1.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉NO₉.

4-Hydroxy Propranolol β-D-Glucuronide Methyl Ester (Mixture of Diastereomers), CAS: /, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₉.

5-Benzyloxy Propranolol-d5 Hydrochloride, CAS: /, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂D₅NO₃ • HCl.

5-Hydroxy Propranolol Hydrochloride, CAS: 62117-35-5, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂ClNO₃.

5-Hydroxy Propranolol-d5, CAS: 1185084-01-8, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₅NO₃.

N-Benzyl 4-Hydroxy Propranolol β-D-Glucuronide, CAS: /, stock: 4.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₅NO₉.

N-Benzyl-4-Hydroxy Propranolol, CAS: /, stock: 3.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇NO₃.

rac 4-Hydroxy Propranolol-d7 β-D-Glucuronide, CAS: /, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂D₇NO₉.

rac 4-Sulfoxy Propranolol, CAS: 87075-33-0, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₆S.

rac 4-Sulfoxy Propranolol-d7 Sodium Salt, CAS: /, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃D₇NNaO₆S.

rac 7-Hydroxy Propranolol, CAS: 81907-81-5, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃.

rac 7-Hydroxy Propranolol-d5, CAS: 1184982-94-2, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₅NO₃.

rac Propranolol β-D-Glucuronide Sodium Salt, CAS: /, stock: 5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈NNaO₈.

rac Propranolol β-D-Glucuronide Triacetate Methyl Ester, CAS: /, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₇NO₁₁.

rac Propranolol-d7 β-D-Glucuronide Sodium Salt, CAS: /, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₇NNaO₈.

rac-1-(Azidomethyl)-2-(1-naphthalenyloxy)ethyl β-D-Glucopyranosiduronic Acid Methyl Ester 2’,3’,4’-Triacetate, CAS: /, stock: 1.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉N₃O₁₁.

rac-4-Hydroxy Propranolol Hydrochloride, CAS: 14133-90-5, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂ClNO₃.

rac-4-Hydroxy Propranolol-d7 Hydrochloride, CAS: 1219804-03-1, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅D₇ClNO₃.

rac-Propranolol Methyl-2,3,4-triacetate-β-D-Glucuronide, CAS: /, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₇NO₁₁.

Propiverine N-Oxide Hydrochloride (cis/trans mixture), CAS: 1329509-71-8, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀ClNO₄.

1-(3-Amino-4-methylphenyl)-1-propanone, CAS: 103028-85-9, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

1-(3-Hydroxy-4-methylphenyl)-1-propanone, CAS: 18158-56-0, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

1-(4-Bromo-2-hydroxyphenyl)-1-propanone, CAS: 17764-92-0, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉O₂Br.

1-(4-Chlorophenyl)-2-(ethylamino)-1-propanone-d5, CAS: /, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₅ClNO.

1-(4-Chlorophenyl)-2-(ethylamino)propan-1-one, CAS: 14919-85-8, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClNO.

1-(4-Isopropylphenyl)propan-1-one, CAS: 27465-52-7, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O.

1-(4-Methyl-3-nitrophenyl)-1-propanone, CAS: 50630-41-6, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₃.

1-​(3-​Hydroxyphenyl)​-​1-​propanone, CAS: 13103-80-5, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₂.

1-[2-(3-Bromo-2-hydroxypropoxy)phenyl]-3-phenyl-1-propanone, CAS: 93885-34-8, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉BrO₃.

1-[2-(3-Bromo-2-hydroxypropoxy)phenyl]-3-phenyl-1-propanone-d5, CAS: 1189662-52-9, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₅BrO₃.

2-(Benzylmethylamino)-4’-methylpropiophenone-d3, CAS: /, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈D₃NO.

2-(Propylamino)propiophenone Hydrochloride, CAS: 879667-46-6, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClNO.

2-(Propylamino)propiophenone-d7 Hydrochloride, CAS: 1286167-06-3, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₇ClNO.

2-Amino-3’,4’-dibenzyloxypropiophenone Hydrochloride, CAS: 1219199-37-7, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄ClNO₃.

2-Amino-3’,4’-dihydroxypropiophenone, CAS: 19490-60-9, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₃.

2-Amino-3’,4’-dimethoxypropiophenone Hydrochloride, CAS: 90253-98-8, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClNO₃.

2-Bromo-3’,4’-(methylenedioxy)propiophenone, CAS: 52190-28-0, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrO₃.

2-Bromo-4’-methylpropiophenone, CAS: 1451-82-7, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO.

2-Bromo-4’-methylpropiophenone (1mg/mL in Acetonitrile), CAS: 1451-82-7, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO.

2-Chloro-1-(4-hydroxy-3-methoxyphenyl)propan-1-one, CAS: 68505-86-2, stock: 7.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClO₃.

2-Chloropropiophenone, CAS: 6084-17-9, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉OCl.

2-Fluoropropiophenone, CAS: 446-22-0, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉FO.

2-Hydroxy-4’-(2-hydroxyethoxy)-2-methylpropiophenone, CAS: 106797-53-9, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₄.

2-Methyl-4-bromoindene, CAS: 328085-65-0, stock: 8.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉Br.

2-Propionyl-4-methoxyaniline, CAS: 60997-56-0, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

2-[(2-Hydroxyethyl)methylamino]-1-phenyl-1-propanone Hydrochloride, CAS: /, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂ • HCl.

2’,3’-Difluoropropiophenone, CAS: 101712-19-0, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈OF₂.

2’,4’,5’-Trifluoropropiophenone, CAS: 220228-07-9, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇OF₃.

2’,4’,6’-Trifluoropropiophenone, CAS: 220141-69-5, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇OF₃.

2’,4’-Difluoropropiophenone, CAS: 85068-30-0, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈OF₂.

2’,4’-Dihydroxypropiophenone, CAS: 5792-36-9, stock: 7.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₃.

2’,4’-Dimethoxypropiophenone, CAS: 831-00-5, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

2’,5’-Difluoropropiophenone, CAS: 29112-90-1, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈OF₂.

2’,5’-Dimethoxypropiophenone, CAS: 5803-30-5, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

2’,6’-Difluoropropiophenone, CAS: 85068-31-1, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈OF₂.

2’-Bromopropiophenone, CAS: 62403-86-5, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrO.

2’-Chloro-2-(ethylamino)-propiophenone Hydrochloride, CAS: 879660-23-8, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅Cl₂NO.

2’-Fluoro-3’-(trifluoromethyl)propiophenone, CAS: 207986-23-0, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈OF₄.

2’-Fluoro-5’-(trifluoromethyl)propiophenone, CAS: 207974-18-3, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈OF₄.

2’-Hydroxy-4’-methoxypropiophenone, CAS: 6270-44-6, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

2’-Hydroxypropiophenone, CAS: 610-99-1, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₂.

2’-Methylpropiophenone, CAS: 2040-14-4, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

3,4-Dimethoxypropiophenone, CAS: 1835-04-7, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

3,4-Methylenedioxy Propiophenone, CAS: 28281-49-4, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

3,4’-Dichloropropiophenone, CAS: 3946-29-0, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈OCl₂.

3,4’-Dihydroxy-3’,5’-dimethoxypropiophenone, CAS: 136196-47-9, stock: 7.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₄S.

3-(1-Naphthalenyloxy)propiophenone, CAS: 41198-42-9, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₂.

3-(1-Pyrrolidinyl)propiophenone Hydrochloride, CAS: 833-86-3, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO  •  HCl.

3-(Dimethyl-d6-amino)-4’-bromopropiophenone Hydrochloride, CAS: 1329796-42-0, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₆BrClNO.

3-(Dimethylamino)-4’-bromopropiophenone, CAS: 2138-34-3, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

3-(Dimethylamino)propiophenone Hydrochloride, CAS: 879-72-1, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClNO.

3-Chloro-1-(4-hydroxyphenyl)propan-1-one, CAS: 7182-38-9, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉ClO₂.

3-Chloro-1-(4-methylphenyl)propan-1-one, CAS: 22422-21-5, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁OCl.

3-Chloro-4’-fluoropropiophenone, CAS: 347-93-3, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈OFCl.

3-Dimethylamino-2-methylpropiophenone, CAS: 91-03-2, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO.

3-Morpholinopropiophenone Hydrochloride, CAS: 1020-16-2, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₂ • HCl.

3’,4’,5’-Trifluoropropiophenone, CAS: 220227-74-7, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇OF₃.

3’,4’-Dibenzyloxy-1-phenylpropiophenone, CAS: 17269-65-7, stock: 9.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂O₃.

3’,4’-Dichloropropiophenone, CAS: 6582-42-9, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈Cl₂O.

3’,4’-Dihydroxypropiophenone, CAS: 7451-98-1, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₃.

3’,5’-Bis(Trifluoromethyl)propiophenone, CAS: 85068-34-4, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈OF₆.

3’,5’-Difluoro-4’-hydroxypropiophenone, CAS: 178374-78-2, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₂F₂.

3’-(Trifluoromethyl)propiophenone, CAS: 1533-03-5, stock: 3.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉OF₃.

3’-Aminopropiophenone, CAS: 1197-05-3, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO.

3’-Benzyloxy Propiophenone, CAS: 37951-47-6, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₂.

3’-Bromo-4’-fluoropropiophenone, CAS: 202865-82-5, stock: 9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BrFO.

3’-Bromopropiophenone, CAS: 19829-31-3, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrO.

3’-Chloro-2-bromopropiophenone, CAS: 34911-51-8, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BrClO.

3’-Fluoro-4’-(trifluoromethyl)propiophenone, CAS: 237761-78-3, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈OF₄.

3’-Fluoro-5’-(trifluoromethyl)propiophenone, CAS: 207974-20-7, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈OF₄.

3’-Methoxypropiophenone, CAS: 37951-49-8, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

3’-Methylpropiophenone, CAS: 51772-30-6, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

3’Benzyloxyisonitrosopropiophenone, CAS: /, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₃.

4-Bromomethcathinone Hydrochloride, CAS: 135333-27-6, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BrClNO.

4-Bromomethcathinone-D3 Hydrochloride, CAS: /, stock: 8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₃BrClNO.

4-Ethyl Propiophenone, CAS: 27465-51-6, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O.

4’-(Trifluoromethyl)propiophenone, CAS: 711-33-1, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉OF₃.

4’-Chloro-α-pyrrolidinopropiophenone Hydrochloride, CAS: 93307-24-5, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇Cl₂NO.

4’-Cyanopropiophenone, CAS: 52129-98-3, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO.

4’-Fluoro-3’-(trifluoromethyl)propiophenone, CAS: 239107-27-8, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈OF₄.

4’-Fluoropropiophenone, CAS: 456-03-1, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉FO.

4’-Methoxypropiophenone-d3, CAS: 89717-81-7, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₃O₂.

4’-Methyl-α-pyrrolidinohexanophenone-d8 Hydrochloride, CAS: 1794811-26-9, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₈ClNO.

4’-tert-Butylpropiophenone, CAS: 71209-71-7, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O.

4′-Methylpropiophenone, CAS: 5337-93-9, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

5-Hydroxy Kynuramine Hydrochloride, CAS: 4098-55-9, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₂•HCl.

5’-Bromo-2’-hydroxypropiophenone, CAS: 17764-93-1, stock: 1.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉O₂Br.

Dyclonine Hydrochloride, CAS: 536-43-6, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈ClNO₂.

Eperisone Hydrochloride, CAS: 56839-43-1, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆ClNO.

Eperisone-d10 Hydrochloride, CAS: 1246819-46-4, stock: 8.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₁₀ClNO.

Eprazinone Dihydrochloride, CAS: 10402-53-6, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄Cl₂N₂O₂.

α-Bromopropiophenone, CAS: 2114-00-3, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrO.

α-Bromopropiophenone-d5, CAS: 87258-66-0, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄D₅BrO.

α-Phthalimidopropiophenone, CAS: 19437-20-8, stock: 7.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃NO₃.

β-N-Benzyl-N’-methylaminopropiophenone, CAS: 21970-65-0, stock: 3.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO.

N-Phenylmethcathinone Hydrochloride (1.0 mg/mL in Methanol), CAS: 42787-67-7, stock: 7.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO • HCl.

Oxyfedrine, CAS: 15687-41-9, stock: 8.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₃.

Propiocaine Hydrochloride, CAS: 1155-49-3, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆ClNO₂.

Propiocaine-d10 Hydrochloride, CAS: 1246819-90-8, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₁₀ClNO₂.

Propiophenone, CAS: 93-55-0, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O.

Propiophenone-d5, CAS: 54419-23-7, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅D₅O.

Tolperisone Hydrochloride, CAS: 3644-61-9, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClNO.

U-0521, CAS: 5466-89-7, stock: 8.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

Vanilloylacetyl, CAS: 2034-60-8, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

2,2-Dimethyl-4-isopropyl-1,3-benzodioxole, CAS: 201166-22-5, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂.

2,2’-(2-Hydroxy-1,3-phenylene)bis(propan-2-ol-d12), CAS: /, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₁₂O₃.

2,3,4-Tri-O-benzoyl Propofol-β-D-glucuronide Methyl Ester, CAS: /, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₀O₁₀.

2’,3’,4’-Tri-O-benzoyl Propofol-d17 β-D-Glucuronide Methyl Ester, CAS: /, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₂₃D₁₇O₁₀.

3,3’,5,5’-Tetraisopropyldiphenoquinone, CAS: 2178-51-0, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂O₂.

4-Hydroxy Propofol 4-O-β-D-Glucuronide, CAS: 115005-78-2, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆O₈.

4-Hydroxy Propofol Sulfate Sodium Salt, CAS: /, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NaO₅S.

Aquavan, CAS: 258516-87-9, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉Na₂O₅P.

Aquavan-d17, CAS: /, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂D₁₇Na₂O₅P.

Methyl 2-Hydroxy-3-(2-hydroxypropan-2-yl-d6)benzoate, CAS: /, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₆O₄.

Propofol 1,4-Bis(sodium Sulfate), CAS: /, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆Na₂O₈S₂.

Propofol 4-Carboxylic Acid Isopropyl Ester, CAS: /, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄O₃.

Propofol 4-Hydroxy 1-Sodium Sulfate Salt, CAS: /, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NaO₅S.

Propofol Glucuronide-d17 Methyl Ester, CAS: /, stock: 10g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₁D₁₇O₇.

Propofol β-D-Glucuronide, CAS: 114991-26-3, stock: 6.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆O₇.

Propofol β-D-Glucuronide Lithium Salt, CAS: /, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅LiO₇.

Propofol β-D-Glucuronide Methyl Ester, CAS: /, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈O₇.

Propofol-d17 β-D-Glucuronide, CAS: /, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₉D₁₇O₇.

1,2-Pentanediol, CAS: 5343-92-0, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂O₂.

1,2-Pentanediol-d5, CAS: /, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₅O₂.

1,2-Pentanediol-d7, CAS: /, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₇O₂.

1-(2,4-Dichlorophenyl)-2-(4H-1,2,4-triazol-4-yl)ethanone, CAS: 132653-23-7, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇Cl₂N₃O.

2-(2,4-Dichlorophenyl)-2-methyl-4-propyl-1,3-dioxolane-d7, CAS: /, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₇Cl₂O₂.

Destriazolyl Bromo Propiconazole (Mixture of Diastereomers), CAS: 60207-89-8, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅BrCl₂O₂.

Destriazolyl Bromo Propiconazole-d7, CAS: /, stock: 3.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈D₇BrCl₂O₂.

Propiconazole, CAS: 60207-90-1, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇Cl₂N₃O₂.

Propiconazole-4H-1,2,4-triazole(Mixture of Diastereomers), CAS: 221132-58-7, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇Cl₂N₃O₂.

Propiconazole-d7, CAS: 1246818-14-3, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₇Cl₂N₃O₂.

Propylmagnesium Bromide-d7, CAS: /, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃D₇BrMg.

(1R,3S)-3-[(tert-Butoxycarbonyl)amino]cyclopentanecarboxylic Acid, CAS: 161660-94-2, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄.

(2R,5R)-2,5-Dihydro-3,6-dimethoxy-2-[(2S)-2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutyl]-5-(1-methylethyl)pyrazine, CAS: /, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂N₂O₅.

(2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid, CAS: /, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₆.

(2R,5S,10aS,10bS)-10b-hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid Ethyl Ester, CAS: /, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O₆.

(2R,5S,10aS,10bS)-8-Acetoxy-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid Ethyl Ester, CAS: /, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₂O₈.

(2R,5S,10aS,10bS)-Octahydro-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid, CAS: 24177-07-9, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆N₂O₆.

(2S,5R)-2,5-Dihydro-3,6-dimethoxy-2-[(2S)-2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutyl]-5-(1-methylethyl)pyrazine, CAS: 656241-17-7, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂N₂O₅.

(2S,6S,8S,11S)-1,10-Diazatricyclo[6.4.01,8.02.6]dodecan-9,12-dione, CAS: 129048-16-4, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂.

(2Z)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one, CAS: 1803026-54-1, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂F₆N₄O.

(3S,8aS)-7-(Acetyloxy)hexahydro-3-(phenylmethyl)pyrrolo[1,2-a]pyrazine-1,4-dione, CAS: /, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₄.

(5’α,10α)-1-Demethyl-9,10-dihydro-12’-hydroxy-2’-methyl-5’-(phenylmethyl)-2,3(2H,3H)-secoergotaman-3,3’,6’,18-tetrone, CAS: 81149-12-4, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇N₅O₆.

(R)-2,5-Dihydro-3,6-diethoxy-2-isopropylpyrazine, CAS: 110117-71-0, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀N₂O₂.

(R)-2-(4-Hydroxybutan-2-yl)-9-methoxy-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxylic Acid, CAS: /, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₆.

(R)-2-(4-Hydroxybutan-2-yl)-9-methoxy-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxylic Acid, CAS: /, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₆.

(R)-2-Chloro-7-ethyl-8-isopropyl-5-methyl-7,8-dihydropteridin-6(5H)-one, CAS: 877676-50-1, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇ClN₄O.

(R)-2-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazine (>85% Purity), CAS: 109838-85-9, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂O₂.

(R)-3-Acetyl-1-Boc-pyrrolidine, CAS: 1374673-69-4, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₃.

(R)-3-Amino-N-((R)-4-oxo-1-phenyl-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide, CAS: /, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆F₆N₆O₂.

(R)-3-Amino-N-((R)-4-oxo-1-phenyl-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide-d4, CAS: /, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂D₄F₆N₆O₂.

(R)-Chroman-4-amine Hydrochloride, CAS: 730980-59-3, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClNO.

(R)-N-(2,4-Difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-2,3,4,8-tetrahydro-1H-pyrido[1,2-a]pyrazine-7-carboxamide, CAS: /, stock: 9.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉F₂N₃O₅.

(R)-tert-Butyl 3-Oxotetrahydro-1H-oxazolo[3,4-a]pyrazine-7(3H)-carboxylate, CAS: 1235469-36-9, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂O₄.

(S)-1-Methyl-3-pyrrolidinol, CAS: 104641-59-0, stock: 7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO.

(S)-2-(4-Hydroxybutan-2-yl)-9-methoxy-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxylic Acid, CAS: /, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₆.

(S)-2-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazine, CAS: 78342-42-4, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂O₂.

(S)-3-Acetyl-1-Boc-pyrrolidine, CAS: 1374673-89-8, stock: 8.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₃.

1,1-Dimethyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine, CAS: 1215295-90-1, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂.

1,2,3,4-Tetrahydro-1-methylpyrrolo[1,2-a]pyrazine, CAS: 73627-18-6, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂.

1,3-Benzothiazol-2-ylacetonitrile, CAS: 56278-50-3, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆N₂S.

1,4,5,6-Tetrahydro-5,6-dioxo-2,3-pyrazinedicarbonitrile, CAS: 36023-64-0, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂N₄O₂.

1,6-Dihydro-3,5-dimethyl-6-oxo 2-Pyrazinecarboxylic Acid Ethyl Ester, CAS: 1166827-49-1, stock: 1.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₃.

1,​1-​Dimethylethyl Ester 1,​3,​4,​6-​Tetrahydro-​6-​oxo-​2H-pyrido[1,2-a]pyrazine-2-carboxylic Acid, CAS: 1421065-63-5, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃.

1-(2-Phenoxyphenyl)ethanone, CAS: 26388-13-6, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₂.

1-(4-Chloro-phenyl)-1,2,3,4-tetrahydro-pyrrolo[1,2-a]pyrazine, CAS: 112758-91-5, stock: 3.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₂Cl.

1-(4-Fluoro-phenyl)-1,2,3,4-tetrahydro-pyrrolo[1,2-a]pyrazine, CAS: 112767-38-1, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₂F.

1-(4-Methoxyphenyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine, CAS: 112758-90-4, stock: 7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O.

1-(Boc-piperidin-4-yl)-pyrazole-4-boronate, CAS: 1190875-39-8, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂BN₃O₄.

1-Acetyl-3-Piperidinone, CAS: 34456-78-5, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₂.

1-Bromo-3-methylimidazo[1,5-a]pyrazine, CAS: 56481-29-9, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆BrN₃.

1-Bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine, CAS: 1188265-59-9, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₃Br.

1-Bromo-6-chloroimidazo[1,5-a]pyrazine, CAS: 1214875-29-2, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃N₃ClBr.

1-Ethyl-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine Hydrochloride, CAS: 1185292-97-0, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂ • HCl.

1-Methyl-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-6-carbonitrile, CAS: 1173146-03-6, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃.

1-Methyl-N-(propan-2-yl)-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-6-carboxamide, CAS: 1087792-06-0, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉N₃O.

1-Methyloctahydropyrrolo[1,2-a]pyrazine, CAS: 155206-39-6, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂.

1-Phenyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine, CAS: 112758-89-1, stock: 9.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂.

1-Propyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine, CAS: 112758-86-8, stock: 3.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂.

1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-1-butanone, CAS: 1253056-01-7, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₆N₄O₂.

2,2,3,3-Tetrafluoro-2,3-dihydro-1,4-benzodioxin-5-amine, CAS: 119895-70-4, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅F₄NO₂.

2,2’-Bipyrazine, CAS: 10199-00-5, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₄.

2,3-Diamino-5-bromopyrazine, CAS: 89123-58-0, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅BrN₄.

2,3-Dibromopyrazine, CAS: 95538-03-7, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂Br₂N₂.

2,3-Dichloro-5-(methylthio)pyrazine, CAS: 1174517-48-6, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂SCl₂.

2,3-Dichloropyrazine, CAS: 4858-85-9, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂Cl₂N₂.

2,3-Dicyano-5,6-diphenylpyrazine, CAS: 52197-23-6, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀N₄.

2,3-Diethyl-5-methylpyrazine, CAS: 18138-04-0, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂.

2,3-Diethyl-5-methylpyrazine-N1-oxide, CAS: 1076200-00-4, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O.

2,3-Diethyl-5-methylpyrazine-N4-oxide, CAS: 1076200-01-5, stock: 8.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O.

2,3-Dimethyl-5-ethylpyrazine, CAS: 15707-34-3, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂.

2,3-Dimethylpyrazine, CAS: 5910-89-4, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂.

2,3-Pyrazinedicarboxylic Acid, CAS: 89-01-0, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₄.

2,4-Diamino-6-(hydroxymethyl)pteridine Hydrochloride, CAS: 73978-41-3, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉ClN₆O.

2,4-Dichloro-6-methoxypyrimidine, CAS: 43212-41-5, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄Cl₂N₂O.

2,4-Dichloropyridine, CAS: 26452-80-2, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃Cl₂N.

2,5-Deoxyfructosazine, CAS: 17460-13-8, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₇.

2,5-Deoxyfructosazine-13C4, CAS: 1246815-27-9, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₄H₂₀N₂O₇.

2,5-Di-4-pyridinylpyrazine, CAS: 524919-23-1, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₄.

2,5-Di-4-pyridinylpyrimidine, CAS: 159488-46-7, stock: 4.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₄.

2,5-Dibromopyrazine, CAS: 23229-26-7, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂Br₂N₂.

2,5-Dichloropyrazine, CAS: 19745-07-4, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂N₂Cl₂.

2,5-Difluorobenzyl Bromide, CAS: 85117-99-3, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrF₂.

2,5-Difluoropyrazine, CAS: 1207861-11-7, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂N₂F₂.

2,5-Diiodopyrazine, CAS: 1093418-77-9, stock: 1.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂I₂N₂.

2,5-Dimethoxypyrazine, CAS: 117856-61-8, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₂.

2,5-Pyrazinedipropanoic Acid Dimethyl Ester, CAS: 77479-01-7, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₄.

2,6-Daminopyrazine, CAS: 41536-80-5, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄.

2,6-Deoxyfructosazine, CAS: 36806-15-2, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₇.

2,6-Deoxyfructosazine-13C4, CAS: 1246817-52-6, stock: 5.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₄H₂₀N₂O₇.

2,6-Dibromopyrazine, CAS: 23229-25-6, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂Br₂N₂.

2,6-Dichloropyrazine, CAS: 4774-14-5, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂Cl₂N₂.

2,6-Diiodopyrazine, CAS: 58138-79-7, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂N₂I₂.

2,6-Dimethoxypyrazine, CAS: 4774-15-6, stock: 6.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₂.

2,6-Dimethylpyrazine, CAS: 108-50-9, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂.

2,7-Dibromo-5H-pyrrolo[2,3-b]pyrazine, CAS: 1209703-87-6, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Br₂N₃.

2,​2,​3,​3,​3-​Pentafluoropropanoic Acid, CAS: 422-64-0, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃HF₅O₂.

2,​2,​3,​3,​3-​Pentafluoropropanoic Acid-13C, CAS: /, stock: 7.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³CHF₅O₂.

2,​3-​Pyrazinedicarboxylic Anhydride, CAS: 4744-50-7, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂N₂O₃.

2-(1,1-Difluoroethyl)pyrazine, CAS: 111781-49-8, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂F₂.

2-(1-Acetoxyethyl)-3-ethyl-5-methylpyrazine, CAS: 1076198-72-5, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂.

2-(1H-Imidazol-2-yl)pyrazine, CAS: 119165-68-3, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₄.

2-(1H-Pyrazol-3-yl)pyrazine, CAS: 111781-54-5, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₄.

2-(3-(1-Oxo-1H-pyrrolo[2,1-c][1,4]oxazin-3-yl)propyl)isoindoline-1,3-dione, CAS: /, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄N₂O₄.

2-(3-Chloro-4-methylphenyl)pyrazine, CAS: 1355247-55-0, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉N₂Cl.

2-(4-Chlorobenzoyl)pyrazine, CAS: 118543-85-4, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇N₂OCl.

2-(4-Fluorobenzoyl)pyrazine, CAS: 118543-82-1, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇N₂OF.

2-(5-Chloromethyl-[1,2,4]oxadiazol-3-yl)-pyrazine, CAS: 114346-91-7, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₄OCl.

2-(Aminomethyl)-5-methylpyrazine, CAS: 132664-85-8, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃.

2-(Benzyloxy)-6-chloropyrazine, CAS: 4774-18-9, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉N₂OCl.

2-(Bromomethyl)-1-chloro-4-(trifluoromethyl)-benzene, CAS: 237761-77-2, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrClF₃.

2-(chloromethyl)-5-methylpyrazine hydrochloride, 95%, CAS: 128229-06-1, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₂  • HCl.

2-(Furan-2-ylmethylsulfanyl)-3-methylpyrazine, CAS: 59303-07-0, stock: 2.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂OS.

2-(Methoxy-d3)-3-(2-methylpropyl)pyrazine, CAS: 588732-63-2, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₃N₂O.

2-(Methylthio)pyrazine, CAS: 21948-70-9, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂S.

2-(Piperazin-1-yl)pyrazine Hydrochloride, CAS: 61655-78-5, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₄ • (HCl).

2-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine, CAS: 126069-70-3, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₃F₃.

2-(Trifluoromethyl)imidazo[1,2-a]pyrazine, CAS: 109113-96-4, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₃F₃.

2-Acetoxyisobutyryl Chloride, CAS: 40635-66-3, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉ClO₃.

2-Acetyl-3,5-dimethylpyrazine, CAS: 54300-08-2, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O.

2-Acetyl-3-ethylpyrazine, CAS: 32974-92-8, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O.

2-Amino-3,5-dibromo-6-methylpyridine, CAS: 91872-10-5, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂Br₂.

2-Amino-3,5-dibromopyrazine, CAS: 24241-18-7, stock: 6.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃Br₂N₃.

2-Amino-3-(dimethylamino)pyrazine, CAS: 89488-74-4, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₄.

2-Amino-3-(ethylamino)pyrazine, CAS: 912773-15-0, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₄.

2-Amino-3-benzyloxy-5-bromopyrazine, CAS: 187973-44-0, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀BrN₃O.

2-Amino-3-benzyloxypyrazine, CAS: 110223-15-9, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O.

2-Amino-3-bromo-5-chloropyrazine, CAS: 76537-18-3, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃BrClN₃.

2-Amino-3-bromo-5-methylpyrazine, CAS: 74290-65-6, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆BrN₃.

2-Amino-3-bromo-5-methylpyridine, CAS: 17282-00-7, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇BrN₂.

2-Amino-3-bromo-6-chloropyrazine, CAS: 212779-21-0, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃BrClN₃.

2-Amino-3-bromopyrazine-5-carboxylic Acid, CAS: 887352-34-3, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄BrN₃O₂.

2-Amino-3-chloro-5-methylpyrazine, CAS: 89182-14-9, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆ClN₃.

2-Amino-3-ethoxypyrazine, CAS: 89464-86-8, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O.

2-Amino-3-ethynylpyrazine, CAS: 1005349-13-2, stock: 8.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₃.

2-Amino-3-hydroxypyrazine, CAS: 43029-19-2, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O.

2-Amino-3-methylpyrazine, CAS: 19838-08-5, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃.

2-Amino-3-piperazin-1-ylpyrazine, CAS: 59215-43-9, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃N₅.

2-Amino-5-bromo-3-(diethylamino)pyrazine, CAS: 912773-09-2, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃BrN₄.

2-Amino-5-bromo-3-(ethylamino)pyrazine, CAS: 117719-10-5, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₄Br.

2-Amino-5-bromo-3-ethoxypyrazine, CAS: 77112-66-4, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈BrN₃O.

2-Amino-5-bromo-3-ethynylpyrazine, CAS: 1209289-08-6, stock: 1.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrN₃.

2-Amino-5-bromo-3-piperidin-1-ylpyrazine, CAS: 90674-84-3, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₄Br.

2-Amino-5-bromo-3-pyrrolidin-1-ylpyrazine, CAS: 893611-72-8, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₄Br.

2-Amino-5-bromo-6-methylpyrazine, CAS: 74290-69-0, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆BrN₃.

2-Amino-5-bromopyrazine, CAS: 59489-71-3, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄BrN₃.

2-Amino-5-bromopyrazine-3-carboxylic Acid, CAS: 486424-37-7, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄BrN₃O₂.

2-Amino-5-bromopyrazine-3-carboxylic Acid Methyl Ester, CAS: 04/01/6966, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆BrN₃O₂.

2-Amino-5-chloro-3-methoxypyrazine, CAS: 874-31-7, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆ClN₃O.

2-Amino-5-chlorobenzonitrile, CAS: 5922-60-1, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅ClN₂.

2-Amino-5-chloropyrazine, CAS: 33332-29-5, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₃Cl.

2-Amino-5-ethylpyrazine, CAS: 13535-07-4, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃.

2-Amino-5-iodopyrazine, CAS: 886860-50-0, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₃I.

2-Amino-5-methylpyrazine Hydrochloride, CAS: 1159824-25-5, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃ • HCl.

2-Amino-5-Phenylpyrazine, CAS: 13535-13-2, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N₃.

2-Amino-6-bromopyrazine, CAS: 54237-53-5, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄BrN₃.

2-Amino-6-bromothiazolo[4,5-b]pyrazine, CAS: 112342-72-0, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃BrN₄S.

2-Amino-6-cyanopyrazine, CAS: 59489-39-3, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₄.

2-Amino-6-methoxypyrazine, CAS: 6905-47-1, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃O.

2-Aminopyrazine, CAS: 5049-61-6, stock: 8.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃.

2-Aminopyrazine-5-carboxylic Acid Methyl Ester, CAS: 13924-94-2, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₃O₂.

2-Aminoquinoxaline, CAS: 05/05/5424, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃.

2-​(Methoxy-​d3)​-​3-​(1-​methylethyl)​pyrazine, CAS: 588732-60-9, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₃N₂O.

2-​(Methoxy-​d3)​-​3-​(1-​methylethyl)​pyrazine (100µg/ml in Methanol), CAS: 588732-60-9, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₃N₂O.

2-​Bromo-​3-​fluoropyrazine, CAS: 206278-27-5, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂BrFN₂.

2-Bromo-3,5-dichloropyrazine, CAS: 1206249-40-2, stock: 1.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HN₂Cl₂Br.

2-Bromo-3-methoxypyrazine, CAS: 1209905-41-8, stock: 5.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₂OBr.

2-Bromo-3-methylpyrazine, CAS: 120984-76-1, stock: 6.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅BrN₂.

2-Bromo-5(4-piperidinone-1-yl)pyrazine, CAS: 1100752-74-6, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₃OBr.

2-Bromo-5-(methylsulfanyl)pyrazine, CAS: 1049026-49-4, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅BrN₂S.

2-Bromo-5-(methylsulfonyl)pyrazine, CAS: 1177421-54-3, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₂O₂SBr.

2-Bromo-5-chloropyrazine, CAS: 912773-21-8, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂BrClN₂.

2-Bromo-5-cyanopyrazine, CAS: 221295-04-1, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂BrN₃.

2-Bromo-5-cyclopropylpyrazine, CAS: 1086382-78-6, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₂Br.

2-Bromo-5-ethoxypyrazine, CAS: 1060803-83-9, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₂OBr.

2-Bromo-5-fluoropyrazine, CAS: 1209459-10-8, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂N₂FBr.

2-Bromo-5-hydrazinopyrazine, CAS: 1001050-24-3, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₄Br.

2-Bromo-5-methoxypyrazine, CAS: 143250-10-6, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅BrN₂O.

2-Bromo-5-methylpyrazine, CAS: 98006-90-7, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅BrN₂.

2-Bromo-5-nitropyrazine, CAS: 117103-53-4, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂N₃O₂Br.

2-Bromo-5-tosyl-5H-pyrrolo[2,3-b]pyrazine, CAS: 1201186-54-0, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀BrN₃O₂S.

2-Bromo-5h-pyrrolo[2,3-b]pyrazine, CAS: 875781-43-4, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrN₃.

2-Bromo-5H-pyrrolo[2,3-b]pyrazine-7-carbaldehyde, CAS: 1185428-32-3, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₃OBr.

2-Bromo-6-chloropyrazine, CAS: 916791-07-6, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂BrClN₂.

2-Bromo-6-cyanopyrazine, CAS: 859064-02-1, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂BrN₃.

2-Bromo-6-methylpyrazine, CAS: 914452-71-4, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅BrN₂.

2-Bromo-6-methylpyrazino[2,3-b]pyrazine, CAS: 91225-51-3, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrN₄.

2-Bromo-7-iodo-5H-pyrrolo[2,3-b]pyrazine, CAS: 875781-44-5, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃N₃BrI.

2-Bromopropionaldehyde Diethyl Acetal, CAS: 3400-55-3, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅BrO₂.

2-Bromopyrazine, CAS: 56423-63-3, stock: 3.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃BrN₂.

2-Butyl-3-methylpyrazine, CAS: 15987-00-5, stock: 5.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂.

2-Chloro-3,5-dimethylpyrazine, CAS: 38557-72-1, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₂.

2-Chloro-3-(1-piperazinyl)pyrazine, CAS: 85386-99-8, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁ClN₄.

2-Chloro-3-(1H-pyrrol-1-yl)pyridine, CAS: 70291-26-8, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇N₂Cl.

2-Chloro-3-(piperazin-1-yl)pyrazine Hydrochloride, CAS: 66522-30-3, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂Cl₂N₄.

2-Chloro-3-(propan-2-yloxy)pyrazine, CAS: 1209457-92-0, stock: 6.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₂OCl.

2-Chloro-3-ethoxypyrazine, CAS: 1126824-36-9, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₂OCl.

2-Chloro-3-hydrazinylpyrazine, CAS: 63286-28-2, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₄Cl.

2-Chloro-3-methoxypyrazine, CAS: 40155-28-0, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₂OCl.

2-Chloro-3-pyrrolidin-1-ylpyrazine, CAS: 1209459-63-1, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀ClN₃.

2-Chloro-5,6-diphenylpyrazine, CAS: 41270-66-0, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁ClN₂.

2-Chloro-5-(chloromethyl)pyrazine, CAS: 105985-21-5, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄Cl₂N₂.

2-Chloro-5-fluoropyridine, CAS: 31301-51-6, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃ClFN.

2-Chloro-5-isopropoxypyrazine, CAS: 1081522-65-7, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₂OCl.

2-Chloro-5-methylpyrazine, CAS: 59303-10-5, stock: 9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₂Cl.

2-Chloro-6-(1-piperazinyl)pyrazine, CAS: 64022-27-1, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁ClN₄.

2-Chloro-6-(1H-1,2,4-triazol-1-yl)pyrazine, CAS: 1086110-85-1, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₅Cl.

2-Chloro-6-(1h-imidazol-1-yl)pyrazine, CAS: 941294-48-0, stock: 9.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₄Cl.

2-Chloro-6-(1H-pyrazol-1-yl)pyrazine, CAS: 642459-09-4, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₄Cl.

2-Chloro-6-(2,2,2-trifluoroethoxy)pyrazine, CAS: 1016530-98-5, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂OF₃Cl.

2-Chloro-6-(2,2,3,3-tetrafluoropropoxy)pyrazine, CAS: 1039858-65-5, stock: 6.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₂OF₄Cl.

2-Chloro-6-(2-methylpropoxy)pyrazine, CAS: 1016508-48-7, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₂OCl.

2-Chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrazine, CAS: 1133082-92-4, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₄Cl.

2-Chloro-6-(3-methoxypropylamino)pyrazine, CAS: 941294-49-1, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂ClN₃O.

2-Chloro-6-(4-methoxybenzyloxy)pyrazine, CAS: 1020995-63-4, stock: 2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁N₂O₂Cl.

2-Chloro-6-(cyclohexyloxy)pyrazine, CAS: 1016681-36-9, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂OCl.

2-Chloro-6-(ethylsulfanyl)pyrazine, CAS: 1094842-83-7, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₂SCl.

2-Chloro-6-(N,N-diethylamino)pyrazine, CAS: 951885-43-1, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂ClN₃.

2-Chloro-6-(N,N-dipropylamino)pyrazine, CAS: 957065-91-7, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆ClN₃.

2-Chloro-6-(piperidin-4-yloxy)pyrazine Hydrochloride, CAS: 1220036-90-7, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₃OCl  •  HCl.

2-Chloro-6-(pyrrolidin-1-yl)pyrazine, CAS: 1000339-30-9, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀ClN₃.

2-Chloro-6-(trifluoromethyl)pyrazine, CAS: 61655-69-4, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂N₂F₃Cl.

2-Chloro-6-cyclohexylaminopyrazine, CAS: 642459-26-5, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN₃.

2-Chloro-6-cyclopropylaminopyrazine, CAS: 941294-47-9, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈ClN₃.

2-Chloro-6-cyclopropylmethoxy-pyrazine, CAS: 1019493-28-7, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₂OCl.

2-Chloro-6-ethylaminopyrazine, CAS: 957065-84-8, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈ClN₃.

2-Chloro-6-hydrazinylpyrazine, CAS: 63286-29-3, stock: 2.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅ClN₄.

2-Chloro-6-isopropoxypyrazine, CAS: 1016698-79-5, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₂OCl.

2-Chloro-6-isopropylaminopyrazine, CAS: 951884-00-7, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀ClN₃.

2-Chloro-6-methoxypyrazine, CAS: 33332-30-8, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₂OCl.

2-Chloro-6-methylaminopyrazine, CAS: 848366-38-1, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆ClN₃.

2-Chloro-6-methylpyrazine, CAS: 38557-71-0, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅ClN₂.

2-Chloro-6-pentylaminopyrazine, CAS: 951884-01-8, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄ClN₃.

2-Chloro-6-propylaminopyrazine, CAS: 951884-52-9, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀ClN₃.

2-Chloro-7-methylquinoxaline, CAS: 90272-84-7, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇N₂Cl.

2-Chloro-pyrido[2,3-b]pyrazine Dihydrochloride, CAS: 1187931-12-9, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₃Cl • 2HCl.

2-Chloropyrazine, CAS: 14508-49-7, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃ClN₂.

2-Ethoxy-3-ethylpyrazine, CAS: 35243-43-7, stock: 2.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O.

2-Ethoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine, CAS: 1186041-95-1, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉BN₂O₃.

2-Ethyl-3,(5 or 6)-dimethylpyrazine, CAS: 27043-05-6, stock: 9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂.

2-Ethyl-3-methylthiopyrazine, CAS: 72987-62-3, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂S.

2-Fluoropyrazine, CAS: 4949-13-7, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃FN₂.

2-Formyl-5,6-dihydro-8H-imidazo[1,2-a]pyrazine-7-carboxylic Acid tert-Butyl Ester, CAS: 1174068-98-4, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O₃.

2-Furfurylthio-3-methylpyrazine, CAS: 65530-53-2, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂OS.

2-Hydroxy-3-trifluoromethylpyridine, CAS: 22245-83-6, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄F₃NO.

2-Hydroxy-4-methylpyridine, CAS: 13466-41-6, stock: 6.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NO.

2-Hydroxy-4-methylpyridine-d3, CAS: 1185316-03-3, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₃NO.

2-Hydroxy-4-methylpyridine-d6, CAS: 916979-13-0, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₆NO.

2-Hydroxy-6-methylpyrazine, CAS: 20721-18-0, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O.

2-Hydroxypyrazine, CAS: 6270-63-9, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂O.

2-Iodo-3-methoxypyrazine, CAS: 58139-04-1, stock: 3.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₂OI.

2-Iodo-6-methoxypyrazine, CAS: 58139-03-0, stock: 1.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₂OI.

2-Iodopyrazine, CAS: 32111-21-0, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₂I.

2-Mercaptopyrazine, CAS: 38521-06-1, stock: 2.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂S.

2-Methoxy-3,5-dimethylpyrazine, CAS: 92508-08-2, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O.

2-Methoxy-3-(tributylstannyl)pyrazine, CAS: 1105511-65-6, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₂N₂OSn.

2-Methoxy-6-(tributylstannyl)pyrazine, CAS: 1105511-66-7, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₂N₂OSn.

2-Methoxypyrazine, CAS: 3149-28-8, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O.

2-Methyl-3-Isopropoxypyrazine, CAS: 94089-22-2, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O.

2-Methyl-5-trifluoromethyl-pyrazine, CAS: 1186195-51-6, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂F₃.

2-Methylpyrazine, CAS: 109-08-0, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂.

2-Methyltetrahydro-2H-pyrazino[1,2-a]pyrazine-1,4(3H,6H)-dione, CAS: 1009597-84-5, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃N₃O₂.

2-Pyrazinecarboxylic Acid 4-Oxide, CAS: 874-54-4, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₃.

2-sec-Butyl-3-methoxypyrazine, CAS: 24168-70-5, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O.

2-Vinylpyrazine, CAS: 4177-16-6, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂.

2-[[(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]amino]succinic Acid, CAS: /, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₇F₆N₅O₃.

2β-Amino-9,10,10aα,10b-tetrahydro-10bβ-hydroxy-5β-isobutyl-2-isopropyl-8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-3,6(2H,5H)-dione Hydrochloride Salt, CAS: 24177-10-4, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈ClN₃O₄.

3,4-Difluoro-5-methoxyaniline, CAS: 1195190-12-5, stock: 8.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇F₂NO.

3,4-Dihydro-1H-pyrrolo[1,2-a]pyrazine-2,6-dicarboxylic Acid 2-tert-Butyl Ester 6-Methyl Ester, CAS: 1363383-12-3, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₄.

3,4-Dihydro-3-oxo-2-pyrazinecarboxamide, CAS: 55321-99-8, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₃O₂.

3,5-Bis(trifluoromethyl)benzyl Bromide, CAS: 32247-96-4, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrF₆.

3,5-Diamino-N-(aminothioxomethyl)-6-chloropyrazinecarboxamide, CAS: 30478-39-8, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₆OS.

3,5-Dibromo-2-chloropyrazine, CAS: 1082843-70-6, stock: 7.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HBr₂ClN₂.

3,5-Dibromo-2-methoxypyrazine, CAS: 1207853-31-3, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂OBr₂.

3,5-Dibromo-2-pyrazinone, CAS: 21943-15-7, stock: 6.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂Br₂N₂O.

3,5-Dichloro-2-pyrazinamine, CAS: 873-42-7, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃Cl₂N₃.

3,5-Dichloro-6-ethyl-2-pyrazinecarboxamide, CAS: 313340-08-8, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇Cl₂N₃O.

3,5-Dichloropyrazine-2-carbaldehyde, CAS: 136866-27-8, stock: 2.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂Cl₂N₂O.

3,5-Dichloropyrazine-2-carbonitrile, CAS: 313339-92-3, stock: 2.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅HCl₂N₃.

3,5-Dichloropyrazine-2-carboxamide, CAS: 312736-50-8, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃Cl₂N₃O.

3,5-Dichloropyrazine-2-carboxylic Acid, CAS: 312736-49-5, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂N₂O₂Cl₂.

3,5-Dimethyl-2-ethyl-d5-pyrazine, CAS: 1082581-96-1, stock: 2.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₅N₂.

3,5-Dimethyl-2-ethylpyrazine, CAS: 13925-07-0, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂.

3,5-Dimethyl-2-ethylpyrazine-d6, CAS: 1189720-18-0, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₆N₂.

3,5-Dimethyl-2-vinylpyrazine, CAS: 157615-33-3, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂.

3,6-Dibromopyrazine-2-carboxylic Acid, CAS: 957230-68-1, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂N₂O₂Br₂.

3,8-Dimethyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1174645-65-8, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₄.

3-(1,3-Benzothiazol-2-yl)pyrazine-2-carboxylic Acid, CAS: 100283-52-1, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇N₃O₂S.

3-(2-Methylpropyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1159554-19-4, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₄.

3-(3-Aminopropyl)-2-methylpyrrolo[1,2-a]pyrazin-1(2H)-one, CAS: 116212-55-6, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O.

3-(3-Aminopropyl)-2-methylpyrrolo[1,2-a]pyrazin-1(2H)-one-d3, CAS: /, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂D₃N₃O.

3-(3-Chloropropyl)-1H-pyrrolo[2,1-c][1,4]oxazin-1-one, CAS: 116212-51-2, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀ClNO₂.

3-(3-Chloropropyl)-2-methylpyrrolo[1,2-a]pyrazin-1(2H)-one, CAS: 116212-53-4, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃ClN₂O.

3-(4-Boc-piperazin-1-ylsulfonyl)phenylboronic Acid Pinacol Ester, CAS: 1033743-83-7, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₃BN₂O₆S.

3-(4-Fluorobenzyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1159553-30-6, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₄F.

3-(Aminocarbonyl)pyrazine-2-carboxylic Acid, CAS: 67367-37-7, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₃O₃.

3-(Chloromethyl)-N-(5-chloro-2-pyridinyl)-2-pyrazinecarboxamide, CAS: 1122549-47-6, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈Cl₂N₄O.

3-(Methoxycarbonyl)-5-((4-nitrobenzyloxy)carbonyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylic acid, CAS: 1255574-57-2, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₄O₈.

3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 486460-21-3, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₄F₃.

3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride, CAS: 762240-92-6, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈ClF₃N₄.

3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-d4 Hydrochloride, CAS: /, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₄ClF₃N₄.

3-Amino-2-pyrazinecarboxylic Acid, CAS: 01/01/5424, stock: 7.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₃O₂.

3-Amino-2-pyrazinecarboxylic Acid Methyl Ester, CAS: 16298-03-6, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₃O₂.

3-Amino-4-(2,4,5-trifluorophenyl)butanyl Sitagliptin, CAS: 2072867-07-1, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃F₉N₆O₂.

3-Amino-5-bromo-1H-pyrazolo[3,4-b]pyrazine, CAS: 1242336-77-1, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₅Br.

3-Amino-5-chloropyrazine-2-carbonitrile, CAS: 54632-11-0, stock: 8.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃ClN₄.

3-Amino-6-(chloromethyl)-2-pyrazinecarbonitrile 4-oxide, CAS: 40127-89-7, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₄OCl.

3-Amino-6-bromo-2-pyrazinemethanol, CAS: 1260880-59-8, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆BrN₃O.

3-Amino-6-bromopyrazine-2-carbonitrile, CAS: 17231-51-5, stock: 7.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃BrN₄.

3-Amino-6-bromopyrazine-2-carboxamide, CAS: 17890-77-6, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅BrN₄O.

3-Amino-6-chloro-5-[(3S)-4-[1-[(4-chlorophenyl)methyl]-4-piperidinyl]-3-ethyl-1-piperazinyl]-2-pyrazinecarboxamide, CAS: 906805-42-3, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁Cl₂N₇O.

3-Amino-6-chloropyrazine-2-carbonitrile, CAS: 17231-50-4, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃ClN₄.

3-Amino-6-chloropyrazine-2-carboxylic Acid, CAS: 2727-13-1, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₃O₂Cl.

3-Amino-N-methylpyrazine-2-carboxamide, CAS: 36204-76-9, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₄O.

3-Aminocyclobutanone Hydrochloride, CAS: 1035374-20-9, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈ClNO.

3-Aminopyrazine-2-carbonitrile, CAS: 25911-65-3, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₄.

3-Aminopyrazine-2-carboxamide, CAS: 32587-10-3, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₄O.

3-Benzyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1035454-21-7, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄.

3-Bromo-2-oxo-1(2H)-pyrazineacetic Acid Ethyl Ester, CAS: 267876-34-6, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BrN₂O₃.

3-Bromo-2-pyrazinamine, CAS: 21943-12-4, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄BrN₃.

3-Bromo-5,6,7,8-tetrahydro-imidazo[1,2-a]pyrazine, CAS: 954239-19-1, stock: 10g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈BrN₃.

3-Bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine Hydrochloride, CAS: 1187830-45-0, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₃Br • HCl.

3-Bromo-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylic Acid tert-Butyl Ester, CAS: 1196154-25-2, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₃O₂Br.

3-Bromo-6-chloroimidazo[1,2-a]pyrazine, CAS: 1214875-36-1, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrClN₃.

3-Bromo-8-chloro-2-methylimidazo[1,2-a]pyrazine, CAS: 1124321-36-3, stock: 3.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₃ClBr.

3-Bromo-8-chloroimidazo[1,2-a]pyrazine, CAS: 143591-61-1, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrClN₃.

3-Bromoimidazo[1,2-a]pyrazine, CAS: 57948-41-1, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrN₃.

3-Bromoimidazo[1,2-a]pyrazine-8-carboxylic Acid, CAS: 1208082-43-2, stock: 4.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₃O₂Br.

3-bromopyrazine-2-carboxylic acid, CAS: 937669-80-2, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃BrN₂O₂.

3-Chloro-2-nitropyrazine, CAS: 87885-43-6, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂ClN₃O₂.

3-Chloro-2-pyrazinamine, CAS: 6863-73-6, stock: 7.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄ClN₃.

3-Chloro-2-pyrazinecarboxylic Acid, CAS: 27398-39-6, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃ClN₂O₂.

3-Chloro-2-pyrazinecarboxylic Acid Methyl Ester, CAS: 27825-21-4, stock: 7.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₂O₂.

3-Chloro-5H-pyrrolo[2,3-b]pyrazine, CAS: 1111638-10-8, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClN₃.

3-Chloropyrazine-2-carbaldehyde, CAS: 121246-96-6, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃N₂OCl.

3-Chloropyrazine-2-carbonitrile, CAS: 55557-52-3, stock: 2.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂ClN₃.

3-Chloropyrazine-2-carboxamide, CAS: 21279-62-9, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₃OCl.

3-Cyclopentyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1159530-90-1, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₄.

3-Desamino-2,3-dehydro Sitagliptin, CAS: 1253056-18-6, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂F₆N₄O.

3-Desamino-3,4-dehydro Sitagliptin, CAS: 1675201-14-5, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂F₆N₄O.

3-Ethoxypyrazine-2-carboxylic acid, CAS: 1339121-92-4, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃.

3-Ethyloctahydro-Pyrrolo[1,2-a]pyrazine, CAS: 1092297-94-3, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂.

3-Iodoimidazo[1,2-a]pyrazine, CAS: 1233689-64-9, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₃I.

3-Methoxypyrazine-2-carboxylic acid, CAS: 40155-47-3, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₃.

3-Methyl-1H-pyrazolo[3,4-b]pyrazine, CAS: 1131041-58-1, stock: 5.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄.

3-Methylazetidine-3-carbonitrile Hydrochloride, CAS: 936850-33-8, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₂ • HCl.

3-Methylimidazo[1,5-a]pyrazine, CAS: 39204-53-0, stock: 5.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₃.

3-Methylpyrazine-2-carboxylic Acid, CAS: 41110-28-5, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

3-Oxo-3,4-dihydropyrazine-2-carboxylic Acid, CAS: 20737-42-2, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₃.

3-Phenethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1159542-70-7, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄.

3-Phenylimidazo[1,2-a]pyrazine, CAS: 1244949-15-2, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉N₃.

3-Piperidin-4-yl-1H-pyrazolo[3,4-b]pyrazine Dihydrochloride, CAS: 1185112-92-8, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅ • 2HCl.

3-tert-Butyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1159553-38-4, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₄.

3-[(2-Fluorophenyl)methyl]-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1159542-76-3, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₄F.

3-[(3-Fluorophenyl)methyl]-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1159553-28-2, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₄F.

3’,4’-Dihydro-2’H-spiro[cyclohexane-1,1’-pyrrolo[1,2-a]pyrazine], CAS: 1210513-03-3, stock: 1.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

3’,4’-Dihydro-2’H-spiro[cyclopentane-1,1’-pyrrolo[1,2-a]pyrazine], CAS: 1210719-18-8, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

4,4’-Bipyrimidine, CAS: 2426-94-0, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₄.

4,5,6,7-Tetrahydro-1,2,3-triazolo[1,5-a]pyrazine Hydrochloride, CAS: 123308-28-1, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₄ • HCl.

4,5,6,7-Tetrahydro-pyrazolo[1,5-a]pyrazine, CAS: 792163-25-8, stock: 6.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃.

4,5,6,7-Tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine, CAS: 123291-54-3, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₄.

4,5,6,7-Tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine-3-carboxamide, CAS: 1293996-12-9, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₅O.

4,7-Dimethoxy-1-indanone, CAS: 52428-09-8, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

4-(Morpholinosulfonyl)phenylboronic Acid Pinacol Ester, CAS: 1401222-64-7, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄BNO₅S.

4-Amino-​N-​(3,​4-​dihydro-​3-​oxo-​2-​pyrazinyl)​benzenesulfonamide, CAS: 115102-84-6, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₄O₃S.

4-Amino-N-(6-chloro-3-methoxypyrazin-2-yl)benzenesulfonamide, CAS: /, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁ClN₄O₃S.

4-​Bromo-​1H-​pyrazole-​3-​carbaldehyde, CAS: 287917-97-9, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃BrN₂O.

4-Bromo-6,7-dihydro-dipyrido[1,2-a:2’,1’-c]pyrazinediium Dibromide, CAS: 54016-00-1, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁Br₃N₂.

4-Bromopyrazolo[1,5-a]pyrazine, CAS: 1246552-49-7, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrN₃.

4-Chloro-2(imino(phenyl)methyl)aniline, CAS: 5606-39-3, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁ClN₂.

4-Chloro-2-butanone, CAS: 6322-49-2, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇ClO.

4-Chloro-thieno[3,2-c]pyridine-2-carboxaldehyde, CAS: 1296224-97-9, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄ClNOS.

4-Chloro-thieno[3,2-c]pyridine-2-carboxylic Acid Methyl Ester, CAS: 1315364-06-7, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆ClNO₂S.

4-Chloropyridine Hydrochloride, CAS: 7379-35-3, stock: 1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅Cl₂N.

4-Cyclohexyl-α-oxobenzeneacetic Acid, CAS: 162405-05-2, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆O₃.

4-Desfluoro Sitagliptin, CAS: 1345822-87-8, stock: 10g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉F₅N₅O₅P.

4-Desfluoro-destrifluoromethyl Sitagliptin Hydrochloride Salt, CAS: /, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈ClF₂N₅O.

4-Oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylic Acid, CAS: 1029721-02-5, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₃O₃.

4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one-d4, CAS: /, stock: 2.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈D₄F₆N₄O₂.

5,6,7,8-Tetrahydro-1,3-dimethyl-imidazo[1,5-a]pyrazine, CAS: 1083317-78-5, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃N₃.

5,6,7,8-Tetrahydro-3-methyl-1,2,4-triazolo[4,3-a]pyrazine, CAS: 886886-04-0, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₄.

5,6,7,8-Tetrahydro-3-phenyl-1,2,4-triazolo[4,3-a]pyrazine, CAS: 944906-91-6, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₄.

5,6,7,8-Tetrahydro-imidazo1,5-apyrazine-1-carboxylic Acid Ethyl Ester Hydrochloride, CAS: 1187929-23-2, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₂ • HCl.

5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride, CAS: 837430-14-5, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₄ • HCl.

5,6,7,8-Tetrahydroimidazo[1,2-a]pyrazine Hydrochloride, CAS: 1187830-84-7, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃ • HCl.

5,6,7,8-Tetrahydroimidazo[1,5-a]pyrazine Dihydrochloride, CAS: 165894-10-0, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃ • 2(HCl).

5,6,7,8-Tetrahydro[1,2,4]triazolo[4,3-a]pyrazine Dihydrochloride, CAS: 1429056-45-0, stock: 7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₄ • 2(HCl).

5,6-Diaminopyrazine-2,3-dicarbonitrile, CAS: 36023-58-2, stock: 2.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₆.

5,6-Dichloro-2,3-dicyanopyrazine, CAS: 56413-95-7, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆Cl₂N₄.

5,6-Dimethylpyrazine-2-carboxylic Acid, CAS: 13515-06-5, stock: 4.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

5,6-Diphenyl-2,3-dihydropyrazine, CAS: 1489-06-1, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂.

5,6-Diphenylpyrazinol, CAS: 18591-57-6, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂N₂O.

5-(2,2-Difluoroethoxy)pyrazine-2-carboxylic Acid, CAS: 1174323-38-6, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O₃F₂.

5-(4-Methoxyphenyl)imidazo[1,5-a]pyrazine-3-carboxylic acid, CAS: 1206969-05-2, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁N₃O₃.

5-(4-Methoxyphenyl)pyrazinamine, CAS: 119738-50-0, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O.

5-(Difluoromethyl)-2-pyrazinamine, CAS: 1785551-80-5, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅F₂N₃.

5-(Difluoromethyl)pyrazine-2-carboxylic Acid, CAS: 1174321-06-2, stock: 9.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₂F₂.

5-(Piperidin-1-yl)pyrazine-2-carboxylic Acid, CAS: 1210707-88-2, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₂.

5-(tert-Butoxy)pyrazine-2-boronic Acid Pinacol Ester, CAS: 1192838-57-5, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃BN₂O₃.

5-(tert-Butoxycarbonyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylic Acid, CAS: 1209492-73-8, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O₄.

5-(Trifluoromethyl)pyrazine-2-carboxylic Acid, CAS: 1060814-50-7, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃N₂O₂F₃.

5-Acetyl-2-chloropyrazine, CAS: 160252-31-3, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₂O.

5-Acetylpyrazine-2-carboxylic Acid, CAS: 118543-96-7, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O₃.

5-Amino-6-chloro-2,3-dicyanopyrazine, CAS: 56413-96-8, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂N₅Cl.

5-Amino-pyrazine-2-carboxylic Acid Ethyl Ester Hydrochloride, CAS: 1187933-09-0, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₃O₂ • HCl.

5-Aminopyrazine-2-boronic Acid Pinacol Ester, CAS: 947249-41-4, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆BN₃O₂.

5-Aminopyrazine-2-carbonitrile, CAS: 113305-94-5, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₄.

5-Aminopyrazine-2-carboxylic Acid, CAS: 40155-43-9, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₃O₂.

5-Boc-4,6,7-trihydro-1,2,3-triazolo[1,5-a]pyrazine, CAS: 1245782-69-7, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₄O₂.

5-Bromo-2,3-dimethoxypyrazine, CAS: 89466-19-3, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇BrN₂O₂.

5-Bromo-2-chloro-3-methoxypyrazine, CAS: 89283-94-3, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂OClBr.

5-Bromo-2-iodo-3-methoxypyrazine, CAS: 476622-89-6, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄BrIN₂O.

5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyrazine, CAS: 1204809-95-9, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂N₄BrI.

5-Bromo-3-methoxy-2-pyrazinamine, CAS: 5900-13-0, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆BrN₃O.

5-Bromo-3-methyl-1H-pyrazolo[3,4-b]pyrazine, CAS: 1086064-35-8, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₄Br.

5-Bromo-6-chloropyrazin-2-amine, CAS: 173253-42-4, stock: 7.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₃ClBr.

5-Bromo-pyrazine-2-carbaldehyde, CAS: 1211534-08-5, stock: 5.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃N₂OBr.

5-Bromoimidazo[1,2-a]pyrazine, CAS: 87597-26-0, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrN₃.

5-Bromopyrazine-2-carboxylic Acid, CAS: 876161-05-6, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃N₂O₂Br.

5-Bromopyrido[3,4-b]pyrazine, CAS: 1159829-75-0, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₃Br.

5-Chloro-1-[2-(2,2,2-trichloroacetyl)-1H-pyrrol-1-yl]-2-pentanone, CAS: 116212-52-3, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁Cl₄NO₂.

5-Chloro-2-hydroxypyrazine, CAS: 89180-45-0, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₂OCl.

5-Chloro-6-methyl-2-pyrazinecarboxylic Acid, CAS: 188781-36-4, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₂O₂.

5-Chloro-N-methoxy-N-methyl-2-pyrazinecarboxamide, CAS: 1211533-01-5, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈ClN₃O₂.

5-Chloro-[1,2,3,4]tetrazolo[1,5-a]pyrazine, CAS: 1210210-69-7, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂N₅Cl.

5-Chloropyrazine-2-carbonitrile, CAS: 36070-75-4, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂ClN₃.

5-Chloropyrazine-2-carboxamide, CAS: 21279-64-1, stock: 7.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₃OCl.

5-Chloropyrazine-2-carboxylic acid, CAS: 36070-80-1, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃ClN₂O₂.

5-Chloropyrazine-2-carboxylic acid hydrazide, CAS: 848952-83-0, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅ClN₄O.

5-Chloropyridazin-3-amine, CAS: 1314978-36-3, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄ClN₃.

5-Cyanopyrazine-2-carboxylic Acid, CAS: 1211533-09-3, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃N₃O₂.

5-Desfluoro Sitagliptin, CAS: 1345822-86-7, stock: 7.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉F₅N₅O₅P.

5-Desfluoro-destrifluoromethyl Sitagliptin Hydrochloride Salt, CAS: /, stock: 4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈ClF₂N₅O.

5-Ethoxypyrazine-2-carboxylic Acid, CAS: 1220330-11-9, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃.

5-Hydroxy-6-methylpicolinic Acid, CAS: 121447-41-4, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

5-Hydroxypyrazine-2-carboxylic Acid, CAS: 34604-60-9, stock: 5.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₃.

5-Hydroxypyrazine-2-carboxylic Acid Methyl Ester, CAS: 13924-95-3, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₃.

5-Hydroxypyrazine-2-carboxylic Acid-13C3, CAS: /, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₃H₄N₂O₃.

5-Hydroxypyrazinecarboxamide, CAS: 13924-96-4, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₃O₂.

5-Hydroxypyrazinecarboxamide-13C3, CAS: /, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₃H₅O₂N₃.

5-Methyl-2(1H)-pyrazinone, CAS: 20721-17-9, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O.

5-Methyl-pyrazine-2-carboxylic Acid, CAS: 5521-55-1, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

5-Methylpyrazine-2,3-dicarbonitrile, CAS: 52197-12-3, stock: 2.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₄.

5-Methylpyrazine-2-carbaldehyde, CAS: 50866-30-3, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O.

5-Methylpyrazine-2-carbonitrile, CAS: 98006-91-8, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₃.

5-O-Benzyl 2-O-Ethyl 6,7-Dihydro-4H-pyrazolo[1,5-a]pyrazine-2,5-dicarboxylate, CAS: 1065066-04-7, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O₄.

5-[(8-Chloro-3-isoquinolinyl)amino]-3-[(1R)-2-(dimethylamino)-1-methylethoxy]-2-pyrazinecarbonitrile, CAS: 1184843-57-9, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉ClN₆O.

5-[(tert-Butoxy)carbonyl]pyrazine-2-carboxylic Acid, CAS: 1192152-97-8, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₄.

5H,6H,7H,8H-imidazo[1,2-a]pyrazine, CAS: 91476-80-1, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃.

5H-Pyrrolo[2,3-b]pyrazine, CAS: 4745-93-1, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₃.

6,7-Dihydro-5h-pyrrolo[3,4-b]pyrazine, CAS: 871792-60-8, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₃.

6,8-Dibromo-2-methylimidazo[1,2-a]pyrazine, CAS: 1208082-91-0, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Br₂N₃.

6,8-Dibromoimidazo[1,2-a]pyrazine, CAS: 63744-22-9, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Br₂N₃.

6,8-Dibromoimidazo[1,2-a]pyrazine, CAS: 654084-41-0, stock: 9.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁Cl₂N₃O₂.

6,8-Dibromo[1,2,4]triazolo[1,5-a]pyrazine, CAS: 944709-42-6, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂Br₂N₄.

6,8-Dichloroimidazo[1,2-a]pyrazine, CAS: 1245645-38-8, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃N₃Cl₂.

6-(Trifluoromethyl)pyrazine-2-carboxylic Acid, CAS: 1060812-74-9, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃N₂O₂F₃.

6-Aminopyrazine-2-carboxylic Acid, CAS: 61442-38-4, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₃O₂.

6-​Fluoro-​3,​4-​dihydro-​4-​[5-​O-​[hydroxy[[hydroxy(ph​osphonooxy)​phosphinyl]​oxy]​phosphinyl]​-​β-​D-​ribofuranosyl]​-​3-​oxo-​pyrazinecarboxamide Sodium Salt (>75%), CAS: 356783-10-3, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅FN₃O₁₅P₃ • x(Na).

6-​Fluoro-​3-​[(trimethylsilyl)​oxy]​-2-​pyrazinecarboxamide, CAS: 1613031-87-0, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂FN₃O₂Si.

6-Bromo-2-methylimidazo[1,2-a]pyrazine, CAS: 1159811-97-8, stock: 4.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆BrN₃.

6-Bromo-3-chloro-imidazo[1,2-a]pyrazine, CAS: 1239441-36-1, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃N₃ClBr.

6-Bromo-3-iodoimidazo[1,2-a]pyrazine, CAS: 1245644-42-1, stock: 5.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrIN₃.

6-Bromo-8-chloroimidazo[1,2-a]pyrazine, CAS: 1208083-37-7, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrClN₃.

6-Bromo-8-methylimidazo[1,2-a]pyrazine, CAS: 1159815-50-5, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₃Br.

6-Bromo-N2,N2-dimethylpyrazine-2,3-diamine, CAS: 89641-34-9, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₄Br.

6-Bromo-[1,2,4]triazolo[1,5-a]pyrazine, CAS: 1233026-51-1, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃BrN₄.

6-Bromoimidazo[1,2-a]pyrazine, CAS: 912773-24-1, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₃Br.

6-Bromoimidazo[1,2-a]pyrazine-2-carboxylic acid, CAS: 1000018-56-3, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄BrN₃O₂.

6-Bromoimidazo[1,2-a]pyrazine-3-carbaldehyde, CAS: 1208084-47-2, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄BrN₃O.

6-Bromopyrido[2,3-b]pyrazine, CAS: 1204298-53-2, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄BrN₃.

6-Chloro-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine, CAS: 1210129-64-8, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈ClN₃.

6-Chloro-2-pyrazinamine, CAS: 33332-28-4, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄ClN₃.

6-Chloro-3,5-dimethylpyrazine-2-carboxamide, CAS: 1166828-19-8, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₃OCl.

6-Chloro-3-iodoimidazo[1,2-a]pyrazine, CAS: 1245645-10-6, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃N₃ClI.

6-Chloro-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1314974-66-7, stock: 4.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃N₄Cl.

6-Chloroimidazo[1,2-a]pyrazine, CAS: 76537-23-0, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₃Cl.

6-Chloropyrazine-2-carbonitrile, CAS: 6863-74-7, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂ClN₃.

6-Chloropyrazine-2-carboxylic Acid, CAS: 23688-89-3, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃ClN₂O₂.

6-Fluoro-3,4-dihydro-3-oxo-4-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-2-pyrazinecarboxamide, CAS: 356782-87-1, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₄FN₃O₉.

6-Methoxypyrazine-2-carboxylic Acid, CAS: 24005-61-6, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₃.

6-Methyl-8-methylsulfanyl-imidazo[1,2-a]pyrazine, CAS: 1094070-46-8, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃S.

6-Methylpyrazinecarboxylic Acid, CAS: 5521-61-9, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

6-Nor-6-cyanodihydroergotamine, CAS: 129882-18-4, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄N₆O₅.

6-[1-[(4-Fluorophenyl)methyl]-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl]-N-methyl-2-pyrazinecarboxamide, CAS: /, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇FN₆O.

7-(4-Methoxyphenyl)-7,8-dihydro-8-oxo-1,2,4-triazolo[4,3-a]pyrazine-3-propanoic Acid, CAS: 912791-23-2, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O₄.

7-(tert-Butoxycarbonyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-3-carboxylic Acid, CAS: 1053656-19-1, stock: 1.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₄O₄.

7-Amino-furo[2,3-b]pyrazine-6-carboxylic acid ethyl ester, CAS: 187732-95-2, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃O₃.

7-Aminothieno[2,3-b]pyrazine-6-carboxylic Acid, CAS: 56881-31-3, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₃O₂S.

7-Boc-3-oxohexahydroimidazo[1,5-a]pyrazine, CAS: 1246551-25-6, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉N₃O₃.

7-Boc-3-phenyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine, CAS: 1226776-87-9, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁N₃O₂.

7-Bromo-6-methylpyrido[2,3-b]pyrazine, CAS: 857203-29-3, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆BrN₃.

7-Bromo-8-methylpyrido[2,3-b]pyrazine, CAS: 116605-69-7, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₃Br.

7-Bromopyrido[2,3-b]pyrazine, CAS: 52333-42-3, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄BrN₃.

7-Bromopyrido[2,3-b]pyrazine-2,3(1h,4h)-dione, CAS: 168123-82-8, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄BrN₃O₂.

7-Bromothieno[2,3-b]pyrazine, CAS: 1126824-72-3, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrN₂S.

7-Fluoro-6-quinolinecarboxaldehyde, CAS: 1185768-18-6, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆FNO.

7-Iodopyrido[2,3-b]pyrazine, CAS: 1120214-98-3, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₃I.

7-tert-Butyl 1-Methyl 5,6-dihydroimidazo[1,5-a]pyrazine-1,7(8H)-dicarboxylate, CAS: 1094091-44-7, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉N₃O₄.

7-tert-Butyl 2-Ethyl 5,6-Dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylate, CAS: 1053656-22-6, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁N₃O₄.

7-tert-Butyl 3-Ethyl 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine-3,7(8H)-dicarboxylate, CAS: 1215852-11-1, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₄O₄.

8-Amino-1,2,4-triazolo[4,3-a]pyrazine, CAS: 68774-79-8, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₅.

8-Bromo-3-iodoimidazo[1,2-a]pyrazine, CAS: 1245644-46-5, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrIN₃.

8-Bromo-6-methylimidazo[1,2-a]pyrazine, CAS: 1025976-69-5, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₃Br.

8-Chloro-2-methylimidazo[1,2-a]pyrazine, CAS: 85333-43-3, stock: 2.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₃Cl.

8-Chloro-3-methyl-1,2,4-triazolo[4,3-a]pyrazine, CAS: 68774-78-7, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₄.

8-Chloroimidazo[1,2-a]pyrazine, CAS: 69214-33-1, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₃Cl.

8-Methyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 1174644-89-3, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₄.

8-Methylpyrido[2,3-b]pyrazine, CAS: 1023817-02-8, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃.

9,10-Dihydro-β-ergocryptine, CAS: 19467-62-0, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₃N₅O₅.

ACDPP, CAS: 37804-11-8, stock: 1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃ClN₆O.

Acetylpyrazine, CAS: 22047-25-2, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O.

Acipimox, CAS: 51037-30-0, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₃.

Acipimox-d4, CAS: 1246816-28-3, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂D₄N₂O₃.

Aloisine RP106, CAS: 496864-15-4, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O.

AZD 2858, CAS: 486424-20-8, stock: 3.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₇O₃S.

BAM 15, CAS: 210302-17-3, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀F₂N₆O.

Benzyl 4-[5-Chloro-1-(2-ethoxy-2-oxoethyl)-6-oxo-1,6-dihydro-4-pyridazinyl]tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 1000018-18-7, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃ClN₄O₅.

Benzyl 4-{[(Tert-butoxycarbonyl)amino]sulfonyl}tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 1000018-21-2, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₆S.

Bevenopran, CAS: 676500-67-7, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₄O₄.

BG45, CAS: 926259-99-6, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₄O.

Bis-benzyl Sitagliptin Maleate Adduct, CAS: /, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₉F₆N₅O₅.

BMN 673, CAS: 1207454-56-5, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄F₂N₆O.

BMN 673-13C,15N2, CAS: /, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³CH₁₄F₂N₄¹⁵N₂O.

BMN 673-d4, CAS: /, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₀D₄F₂N₆O.

CCT245737, CAS: 1489389-18-5, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆F₃N₇O.

Chlorocriptine, CAS: 68944-88-7, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₀ClN₅O₅.

Chloromethyl)-6-methylpyrazine, CAS: 81831-69-8, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₂.

cis-Octahydrothieno[3,4-b]pyrazine 6,6-dioxide, CAS: 1212331-13-9, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂O₂S.

CP 809101, CAS: 479683-64-2, stock: 4.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇ClN₄O.

CP 809101 Hydrochloride, CAS: 1215721-40-6, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₄OCl • HCl.

Cyclo(Gly-L-Gln), CAS: 52662-00-7, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁N₃O₃.

Desfluoro Sitagliptin, CAS: /, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈F₃N₅O.

Dihydroergotamine (+)-Tartrate Salt (2:1), CAS: 5989-77-5, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₇₀H₈₀N₁₀O₁₆)  •  C₄H₆O₆.

Dimethyl Pyrazine-​2,​5-​dicarboxylate, CAS: 13051-89-3, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₄.

Dipyrazino[2,3-f:2’,3’-h]quinoxaline, CAS: 79790-37-7, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆N₆.

Diquat Dibromide Monohydrate, CAS: 6385-62-2, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄Br₂N₂O.

Diquat Dipyridone, CAS: 35022-72-1, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₂.

Diquat-d4 Dibromide, CAS: 85-00-7, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈D₄Br₂N₂.

ent-Sitagliptin Phosphate, CAS: 823817-58-9, stock: 7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈F₆N₅O₅P.

ent-Sitagliptin-d4 Phosphate, CAS: /, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₄F₆N₅O₅P.

Ergosine, CAS: 561-94-4, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇N₅O₅.

Ergotamine (1.0 mg/mL in Methanol), CAS: 113-15-5, stock: 1.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₅N₅O₅.

Ergovaline, CAS: 2873-38-3, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₅N₅O₅.

Ergovaline-d3, CAS: /, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂D₃N₅O₅.

Ethyl 1H,2H,3H,4H-Pyrrolo[1,2-a]pyrazine-1-carboxylate, CAS: 1242850-22-1, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂.

Ethyl 1H-Indazole-7-carboxylate, CAS: 885278-74-0, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O₂.

Ethyl 2-Hydroxypyrido[2,3-b]pyrazine-3-carboxylate, CAS: 114983-15-2, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N₃O₃.

Ethyl 3-chloro-pyrazine-2-carboxylate, CAS: 655247-45-3, stock: 3.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇ClN₂O₂.

Ethyl 3-Hydroxypyrido[2,3-b]pyrazine-2-carboxylate, CAS: 114097-17-5, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N₃O₃.

Ethyl 4,5,6,7-Tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate, CAS: 1029720-98-6, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₂.

Ethyl 4,6-dimethylpyrazolo[1,5-a]pyrazine-2-carboxylate, CAS: 1449598-76-8, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₂.

Ethyl 4-(4-Nitrophenyl)tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 16154-60-2, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₃O₄.

Ethyl 4-chloro-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate, CAS: 1449598-75-7, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀ClN₃O₂.

Ethyl 4-hydroxy-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate, CAS: 1443978-76-4, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₃O₃.

Ethyl 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-3-carboxylate, CAS: 723286-68-8, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₄O₂.

Ethyl 5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-3-carboxylate Hydrochloride, CAS: 1187830-58-5, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃ClN₄O₂.

Ethyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate, CAS: 91476-82-3, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₂.

Ethyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride, CAS: 623906-17-2, stock: 2.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₂.

Ethyl 5-Aminopyrazine-2-carboxylate, CAS: 54013-06-8, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₃O₂.

Ethyl 5-bromo-2-pyrazinecarboxylate, CAS: 36070-83-4, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇BrN₂O₂.

Ethyl 5-Bromo-6-methylpyrazine-2-carboxylate, CAS: 2090914-30-8, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BrN₂O₂.

Ethyl 6-Bromoimidazo[1,2-a]pyrazine-2-carboxylate, CAS: 1208085-94-2, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₃O₂Br.

Ethyl 6-Chloro-3,5-dimethylpyrazine-2-carboxylate, CAS: 1166827-48-0, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₂O₂Cl.

Ethyl 7-Aminothieno[2,3-b]pyrazine-6-carboxylate, CAS: 56881-21-1, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃O₂S.

Ethyl imidazo[1,2-a]pyrazine-2-carboxylate, CAS: 77112-52-8, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃O₂.

Ethyl Pyrazolo[1,5-a]pyrazine-3-carboxylate, CAS: 1219694-61-7, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃O₂.

Ethyl [1,2,4]triazolo[4,3-a]pyrazine-3-carboxylate, CAS: 723286-67-7, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₄O₂.

Favipiravir, CAS: 259793-96-9, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄FN₃O₂.

Favipiravir-13C3, CAS: /, stock: 4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₃H₄FN₃O₂.

Flutimide, CAS: 162666-34-4, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₃.

Fructosazine, CAS: 13185-73-4, stock: 8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₈.

Gilteritinib, CAS: 1254053-43-4, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₄N₈O₃.

Hydroxymethyl-​N-​methylpiperidine, CAS: 7583-53-1, stock: 1.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO.

Imidazo[1,2-a]pyrazine, CAS: 274-79-3, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₃.

Imidazo[1,2-a]pyrazine-2-carbaldehyde, CAS: 1017782-15-8, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₃O.

Imidazo[1,2-a]pyrazine-2-carboxylic Acid, CAS: 77112-53-9, stock: 9.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₃O₂.

Imidazo[1,2-a]pyrazine-3-carbonitrile, CAS: 1208084-33-6, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₄.

Imidazo[1,2-a]pyrazine-8-carboxylic Acid, CAS: 1029144-45-3, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₃O₂.

α-Chlorobenzyl 4-Fluorophenyl Ketone, CAS: 62148-67-8, stock: 4.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀ClFO.

α-Oxo-1,3-benzodioxole-5-acetic Acid, CAS: 62396-98-9, stock: 1.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₅.

KDU691, CAS: 1513879-19-0, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈ClN₅O₂.

L-Valine Amide, CAS: 3014-80-0, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃ClN₂O.

LY 2606368, CAS: 1234015-52-1, stock: 1.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₇O₂.

Methyl 2-Amino-3-bromopyrazine-5-carboxylate, CAS: 1076198-49-6, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆BrN₃O₂.

Methyl 2-Pyrazineacetate, CAS: 370562-35-9, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

Methyl 3,5-dibromopyrazine-2-carboxylate, CAS: 1035818-91-7, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄Br₂N₂O₂.

Methyl 3,6-dibromopyrazine-2-carboxylate, CAS: 13301-04-7, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄Br₂N₂O₂.

Methyl 3,6-Dimethylpyrazinecarboxylate, CAS: 131602-73-8, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₂.

Methyl 3-Amino-6-chloropyrazine-2-carboxylate, CAS: 1458-03-3, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆ClN₃O₂.

Methyl 3-amino-6-iodopyrazine-2-carboxylate, CAS: 1458-16-8, stock: 9.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆IN₃O₂.

Methyl 3-bromo-6-chloropyrazine-2-carboxylate, CAS: 13457-28-8, stock: 1.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrClN₂O₂.

Methyl 3-bromopyrazine-2-carboxylate, CAS: 51171-02-9, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrN₂O₂.

Methyl 3-hydroxypyrazine-2-carboxylate, CAS: 27825-20-3, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₃.

Methyl 3-Methylpyrazine-2-carboxylate, CAS: 41110-29-6, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

Methyl 5-​Chloro-​6-​methylpyrazine-​2-​carboxylate, CAS: 77168-85-5, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇ClN₂O₂.

Methyl 5-​Cyano-​2-​pyrazinecarboxylate, CAS: 138560-54-0, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₃O₂.

Methyl 5-chloropyrazine-2-carboxylate, CAS: 33332-25-1, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₂O₂.

Methyl 6-Aminopyrazine-2-carboxylate, CAS: 118853-60-4, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₃O₂.

Methyl 6-​Methylpyrazine-​2-​carboxylate, CAS: 41110-38-7, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

Methyl 6-bromopyrazine-2-carboxylate, CAS: 40155-34-8, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrN₂O₂.

Methyl 6-Chloropyrazine-2-carboxylate, CAS: 23611-75-8, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂O₂Cl.

Methyl 7-Aminothieno[2,3-b]pyrazine-6-carboxylate, CAS: 244014-85-5, stock: 9.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O₂S.

Methyl 8-Chloroimidazo[1,2-a]pyrazine-2-carboxylate, CAS: 1206981-34-1, stock: 10g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₃O₂Cl.

MK 212 Hydrochloride, CAS: 61655-58-1, stock: 6.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁ClN₄ • HCl.

ML 190, CAS: 1355244-02-8, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₆O₃.

Morphazinamide, CAS: 952-54-5, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₄O₂.

N-(5-Chloro-2-pyridinyl)-2-pyrazinecarboxamide (Zopiclone Impurity), CAS: 349125-10-6, stock: 6.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇ClN₄O.

N-(5-Chloro-2-pyridinyl)-3-(hydroxymethyl)-2-pyrazinecarboxamide, CAS: 1122549-43-2, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉ClN₄O₂.

N-Acetyl Sitagliptin, CAS: 1379666-94-0, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇F₆N₅O₂.

N-Acetyl Sitagliptin-d3, CAS: 1795785-80-6, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃D₃F₆N₅O₂.

N-Boc-2-amino-5-bromopyrazine, CAS: 914349-79-4, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂BrN₃O₂.

N-Boc-2-Amino-5-methylpyrazine, CAS: 369638-68-6, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₃O₂.

N-Boc-3-Cyanopiperidine, CAS: 91419-53-3, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂O₂.

N-Cyclopropyl-1-methyl-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-6-carboxamide, CAS: 1087784-19-7, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O.

N-Ethyl-1-methyl-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-6-carboxamide, CAS: 1087792-08-2, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₃O.

N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, CAS: 1073353-47-5, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀BNO₄S.

N1-(6-Methoxypyrazinyl)sulfanilamide, CAS: 75746-22-4, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₄O₃S.

Naquotinib, CAS: 1448232-80-1, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂N₈O₃.

N’-Hydroxy-2-pyrazinecarboximidamide, CAS: 51285-05-3, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₄O.

Octahydro-1H-Cyclopentapyrazine-1-carboxylic Acid 1,1-Dimethylethyl Ester, CAS: 1211539-11-5, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₂O₂.

Octahydro-2H-pyrazino[1,2-a]pyrazine-2-carboxylic Acid tert-Butyl Ester, CAS: 1159825-34-9, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃N₃O₂.

Octahydropyrrolo[1,2-A]pyrazine, CAS: 5654-83-1, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂.

PA 1 Dihydrochloride, CAS: 1883549-38-9, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆ClN₉O•2HCl.

Pentylpyrazine, CAS: 6303-75-9, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂.

Peramine Hemisulfate, CAS: /, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₅O  1/2H₂SO₄.

Peramine Hydrochloride Salt-d3, CAS: /, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₃ClN₅O.

Pyrazine, CAS: 290-37-9, stock: 4.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂.

Pyrazine 1,4-Dioxide, CAS: 2423-84-9, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂O₂.

Pyrazine 1,4-Dioxide-d4, CAS: 933803-86-2, stock: 2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄D₄N₂O₂.

Pyrazine 1-oxide, CAS: 2423-65-6, stock: 2.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂O.

Pyrazine-2,3-diamine, CAS: 13134-31-1, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄.

Pyrazine-2,3-dicarbonitrile, CAS: 13481-25-9, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂N₄.